
<!DOCTYPE html>
<html lang="en" >
    <head >

        <meta charset="UTF-8" />
        <meta http-equiv="X-UA-Compatible" content="IE=edge" />
        <meta name="HandheldFriendly" content="True" />
        <meta name="MobileOptimized" content="320" />
        <meta name="viewport" content="width=device-width, initial-scale=1.0" />

        
        

        
        
  <link rel="stylesheet" href="/static/assets/style-a68b4900.css" />
<script type="module" crossorigin="" src="/static/assets/base_style-0a3f24ce.js"></script>

  <link rel="stylesheet" href="/static/assets/style-ef962842.css" />
<link rel="stylesheet" href="/static/assets/style-3ade8b5c.css" />
<script type="module" crossorigin="" src="/static/assets/article_style-d757a0dd.js"></script>

  
  
    <style>
  
  
  @media screen and (min-width: 64em) {
    div.pmc-wm {
      background: repeat-y;
      background-image: url("data:image/svg+xml,%3Csvg xmlns='http://www.w3.org/2000/svg' width='20' height='350' xmlns:xlink='http://www.w3.org/1999/xlink'%3E%3Cdefs%3E%3Cfilter x='-.02' y='0' width='1.05' height='1' id='c'%3E%3CfeFlood flood-color='%23FFF'/%3E%3CfeComposite in='SourceGraphic'/%3E%3C/filter%3E%3Ctext id='b' font-family='Helvetica' font-size='11pt' style='opacity:1;fill:%23005ea2;stroke:none;text-anchor:middle' x='175' y='14'%3E%3C/text%3E%3Cpath id='a' style='fill:%23005ea2' d='M0 8h350v3H0z'/%3E%3C/defs%3E%3Cuse xlink:href='%23a' transform='rotate(90 10 10)'/%3E%3Cuse xlink:href='%23b' transform='rotate(90 10 10)' filter='url(%23c)'/%3E%3C/svg%3E");
      padding-left: 3rem;
    }
  }
</style>

  



        
            <link rel="apple-touch-icon"
                  sizes="180x180"
                  href="/static/img/favicons/apple-touch-icon.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="48x48"
                  href="/static/img/favicons/favicon-48x48.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="32x32"
                  href="/static/img/favicons/favicon-32x32.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="16x16"
                  href="/static/img/favicons/favicon-16x16.png" />
            <link rel="manifest" href="/static/img/favicons/site.webmanifest" />
            <link rel="mask-icon"
                  href="/static/img/favicons/safari-pinned-tab.svg"
                  color="#0071bc" />
            <meta name="msapplication-config"
                  content="/static/img/favicons/browserconfig.xml" />
            <meta name="theme-color" content="#ffffff" />
        

        <title>
            EPS8L2 drives colorectal cancer cell proliferation and migration via YBX1-dependent activation of G3BP2 transcription - PMC
        </title>

        
        
  
  <!-- Logging params: Pinger defaults -->
<meta name="ncbi_app" content="cloudpmc-viewer" />
<meta name="ncbi_db" content="pmc" />
<meta name="ncbi_phid" content="4DDE48C689B741F31B48C6002AEE652E.m_1" />
<meta name="ncbi_pinger_stat_url" content="https://pmc.ncbi.nlm.nih.gov/stat" />
<!-- Logging params: Pinger custom -->
<meta name="ncbi_pdid" content="article" />
  
    <link rel="preconnect" href="https://www.google-analytics.com" />

    
        <link rel="preconnect" href="https://cdn.ncbi.nlm.nih.gov" />
    

    <!-- Include USWDS Init Script -->
    <script src="/static/assets/uswds-init.js"></script>


    <meta name="ncbi_domain" content="cddis">
<meta name="ncbi_type" content="fulltext">
<meta name="ncbi_pcid" content="journal">
<meta name="ncbi_feature" content="associated_data">
<link rel="canonical" href="https://pmc.ncbi.nlm.nih.gov/articles/PMC12335500/">
<meta name="robots" content="INDEX,NOFOLLOW,NOARCHIVE">
<meta name="citation_journal_title" content="Cell Death &amp; Disease">
<meta name="citation_title" content="EPS8L2 drives colorectal cancer cell proliferation and migration via YBX1-dependent activation of G3BP2 transcription">
<meta name="citation_author" content="Yimeng Duan">
<meta name="citation_author_institution" content="State Key Laboratory of Metabolic Dysregulation &amp; Prevention and Treatment of Esophageal Cancer, Tianjian Laboratory of Advanced Biomedical Sciences, Academy of Medical Sciences, Zhengzhou University, Zhengzhou, China">
<meta name="citation_author" content="Peixian Li">
<meta name="citation_author_institution" content="State Key Laboratory of Metabolic Dysregulation &amp; Prevention and Treatment of Esophageal Cancer, Tianjian Laboratory of Advanced Biomedical Sciences, Academy of Medical Sciences, Zhengzhou University, Zhengzhou, China">
<meta name="citation_author" content="Yanmei Yang">
<meta name="citation_author_institution" content="State Key Laboratory of Metabolic Dysregulation &amp; Prevention and Treatment of Esophageal Cancer, Tianjian Laboratory of Advanced Biomedical Sciences, Academy of Medical Sciences, Zhengzhou University, Zhengzhou, China">
<meta name="citation_author" content="Guanghua Wu">
<meta name="citation_author_institution" content="State Key Laboratory of Metabolic Dysregulation &amp; Prevention and Treatment of Esophageal Cancer, Tianjian Laboratory of Advanced Biomedical Sciences, Academy of Medical Sciences, Zhengzhou University, Zhengzhou, China">
<meta name="citation_author" content="Hao Xing">
<meta name="citation_author_institution" content="State Key Laboratory of Metabolic Dysregulation &amp; Prevention and Treatment of Esophageal Cancer, Tianjian Laboratory of Advanced Biomedical Sciences, Academy of Medical Sciences, Zhengzhou University, Zhengzhou, China">
<meta name="citation_author" content="Hong Chen">
<meta name="citation_author_institution" content="State Key Laboratory of Metabolic Dysregulation &amp; Prevention and Treatment of Esophageal Cancer, Tianjian Laboratory of Advanced Biomedical Sciences, Academy of Medical Sciences, Zhengzhou University, Zhengzhou, China">
<meta name="citation_author" content="Liangbo Zhao">
<meta name="citation_author_institution" content="State Key Laboratory of Metabolic Dysregulation &amp; Prevention and Treatment of Esophageal Cancer, Tianjian Laboratory of Advanced Biomedical Sciences, Academy of Medical Sciences, Zhengzhou University, Zhengzhou, China">
<meta name="citation_author" content="Lei Liu">
<meta name="citation_author_institution" content="Department of Pathophysiology, School of Basic Medical Sciences, Zhengzhou University, Zhengzhou, China">
<meta name="citation_author" content="Xiao Sun">
<meta name="citation_author_institution" content="State Key Laboratory of Metabolic Dysregulation &amp; Prevention and Treatment of Esophageal Cancer, Tianjian Laboratory of Advanced Biomedical Sciences, Academy of Medical Sciences, Zhengzhou University, Zhengzhou, China">
<meta name="citation_author" content="Shuiling Jin">
<meta name="citation_author_institution" content="Department of Oncology, the First Affiliated Hospital of Zhengzhou University, Zhengzhou, China">
<meta name="citation_author" content="Luyun He">
<meta name="citation_author_institution" content="Department of Pathophysiology, School of Basic Medical Sciences, Zhengzhou University, Zhengzhou, China">
<meta name="citation_author" content="Benyu Liu">
<meta name="citation_author_institution" content="State Key Laboratory of Metabolic Dysregulation &amp; Prevention and Treatment of Esophageal Cancer, Tianjian Laboratory of Advanced Biomedical Sciences, Academy of Medical Sciences, Zhengzhou University, Zhengzhou, China">
<meta name="citation_publication_date" content="2025 Aug 10">
<meta name="citation_volume" content="16">
<meta name="citation_issue" content="1">
<meta name="citation_firstpage" content="605">
<meta name="citation_doi" content="10.1038/s41419-025-07929-x">
<meta name="citation_pmid" content="40783393">
<meta name="citation_abstract_html_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12335500/">
<meta name="citation_fulltext_html_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12335500/">
<meta name="citation_pdf_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12335500/pdf/41419_2025_Article_7929.pdf">
<meta name="description" content="Colorectal cancer (CRC) remains a leading cause of cancer-related mortality worldwide, characterized by molecular heterogeneity and limited therapeutic options. Here, we identified EPS8L2 as a novel driver of colorectal tumorigenesis. EPS8L2 is ...">
<meta name="og:title" content="EPS8L2 drives colorectal cancer cell proliferation and migration via YBX1-dependent activation of G3BP2 transcription">
<meta name="og:type" content="article">
<meta name="og:site_name" content="PubMed Central (PMC)">
<meta name="og:description" content="Colorectal cancer (CRC) remains a leading cause of cancer-related mortality worldwide, characterized by molecular heterogeneity and limited therapeutic options. Here, we identified EPS8L2 as a novel driver of colorectal tumorigenesis. EPS8L2 is ...">
<meta name="og:url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12335500/">
<meta name="og:image" content="https://cdn.ncbi.nlm.nih.gov/pmc/cms/images/pmc-card-share.jpg?_=0">
<meta name="twitter:card" content="summary_large_image">
<meta name="twitter:site" content="@ncbi">
    
    

    </head>
    <body >
        
    <a class="usa-skipnav " href="#main-content">
      Skip to main content
    </a>


        
            

<section class="usa-banner " aria-label="Official website of the United States government" >
    <div class="usa-accordion">
        <header class="usa-banner__header">
            <div class="usa-banner__inner">
                <div class="grid-col-auto">
                    <img aria-hidden="true"
                         class="usa-banner__header-flag"
                         src="/static/img/us_flag.svg"
                         alt="" />
                </div>

                <div class="grid-col-fill tablet:grid-col-auto" aria-hidden="true">
                    <p class="usa-banner__header-text">
                        An official website of the United States government
                    </p>
                    <span class="usa-banner__header-action">Here's how you know</span>
                </div>

                



















    
        <button
            type="button"
        
    
    class="usa-accordion__button usa-banner__button
           

           
               
               
               
               
            

           
           
           
           "
    aria-expanded="false"
    aria-controls="gov-banner-default"
    
    data-testid="storybook-django-banner"
    
    >
    
        

        
                    <span class="usa-banner__button-text">Here's how you know</span>
                

        
    
        
            </button>
        


            </div>
        </header>

        <div class="usa-banner__content usa-accordion__content"
             id="gov-banner-default"
             hidden>
            <div class="grid-row grid-gap-lg">
                <div class="usa-banner__guidance tablet:grid-col-6">
                    <img class="usa-banner__icon usa-media-block__img"
                         src="/static/img/icon-dot-gov.svg"
                         alt=""
                         aria-hidden="true" />
                    <div class="usa-media-block__body">
                        <p>
                            <strong>Official websites use .gov</strong>
                            <br />
                            A
                            <strong>.gov</strong> website belongs to an official
                            government organization in the United States.
                        </p>
                    </div>
                </div>

                <div class="usa-banner__guidance tablet:grid-col-6">
                    <img class="usa-banner__icon usa-media-block__img"
                         src="/static/img/icon-https.svg"
                         alt=""
                         aria-hidden="true" />

                    <div class="usa-media-block__body">
                        <p>
                            <strong>Secure .gov websites use HTTPS</strong>
                            <br />
                            A <strong>lock</strong> (
                            <span class="icon-lock">
                                <svg xmlns="http://www.w3.org/2000/svg"
                                     width="52"
                                     height="64"
                                     viewBox="0 0 52 64"
                                     class="usa-banner__lock-image"
                                     role="graphics-symbol"
                                     aria-labelledby="banner-lock-description"
                                     focusable="false">
                                    <title id="banner-lock-title">Lock</title>
                                    <desc id="banner-lock-description">
                                    Locked padlock icon
                                    </desc>
                                    <path fill="#000000"
                                          fill-rule="evenodd"
                                          d="M26 0c10.493 0 19 8.507 19 19v9h3a4 4 0 0 1 4 4v28a4 4 0 0 1-4 4H4a4 4 0 0 1-4-4V32a4 4 0 0 1 4-4h3v-9C7 8.507 15.507 0 26 0zm0 8c-5.979 0-10.843 4.77-10.996 10.712L15 19v9h22v-9c0-6.075-4.925-11-11-11z" />
                                </svg>
</span>) or <strong>https://</strong> means you've safely
                                connected to the .gov website. Share sensitive
                                information only on official, secure websites.
                            </p>
                        </div>
                    </div>
                </div>
            </div>
        </div>
    </section>

        

        
    
    
    

<div class="usa-overlay">
</div>



<header class="usa-header usa-header--extended usa-header--wide" data-testid="header" data-header >
    <div class="ncbi-header">
        <div class="ncbi-header__container">
            
                <a class="ncbi-header__logo-container" href="https://www.ncbi.nlm.nih.gov/">
                    <img alt="
                                  NCBI home page
                              "
                         class="ncbi-header__logo-image"
                         src="/static/img/ncbi-logos/nih-nlm-ncbi--white.svg" />
                </a>
            

            <!-- Mobile menu hamburger button -->
            



















    
        <button
            type="button"
        
    
    class="usa-menu-btn ncbi-header__hamburger-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    aria-label="Show menu"
    data-testid="navMenuButton"
    
    >
    
        

        
                <svg aria-hidden="true"
                     class="ncbi-hamburger-icon"
                     fill="none"
                     focusable="false"
                     height="21"
                     viewBox="0 0 31 21"
                     width="31"
                     xmlns="http://www.w3.org/2000/svg">
                    <path clip-rule="evenodd"
                          d="M0.125 20.75H30.875V17.3333H0.125V20.75ZM0.125 12.2083H30.875V8.79167H0.125V12.2083ZM0.125 0.25V3.66667H30.875V0.25H0.125Z"
                          fill="#F1F1F1"
                          fill-rule="evenodd" />
                </svg>
            

        
    
        
            </button>
        



            
                <!-- Desktop buttons-->
                <div class="ncbi-header__desktop-buttons">
                    
                        <!-- Desktop search button -->
                        



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--unstyled ncbi-header__desktop-button
           "
    aria-expanded="false"
    aria-controls="search-field-desktop-navigation"
    aria-label="Show search overlay"
    data-testid="toggleSearchPanelButton"
    data-toggle-search-panel-button
    >
    
        

        
                            


    <svg class="usa-icon " role="graphics-symbol" aria-hidden="true"    >
        
        <use xlink:href="/static/img/sprite.svg#search" />
    </svg>


                            Search
                        

        
    
        
            </button>
        


                    

                    <!-- Desktop login dropdown -->
                    
                        <div class="ncbi-header__login-dropdown">
                            



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--unstyled ncbi-header__desktop-button ncbi-header__login-dropdown-button
           "
    aria-expanded="false"
    aria-controls="login-dropdown-menu"
    aria-label="Show login menu"
    data-testid="toggleLoginMenuDropdown"
    data-desktop-login-button
    >
    
        

        
                                


    <svg class="usa-icon " role="graphics-symbol" aria-hidden="true"    >
        
        <use xlink:href="/static/img/sprite.svg#person" />
    </svg>



                                <span data-login-dropdown-text>Log in</span>

                                <!-- Dropdown icon pointing up -->
                                


    <svg class="usa-icon ncbi-header__login-dropdown-icon ncbi-header__login-dropdown-icon--expand-less ncbi-header__login-dropdown-icon--hidden" role="graphics-symbol" aria-hidden="true"    data-login-dropdown-up-arrow>
        
        <use xlink:href="/static/img/sprite.svg#expand_less" />
    </svg>



                                <!-- Dropdown icon pointing down -->
                                


    <svg class="usa-icon ncbi-header__login-dropdown-icon ncbi-header__login-dropdown-icon--expand-more ncbi-header__login-dropdown-icon--hidden" role="graphics-symbol" aria-hidden="true"    data-login-dropdown-down-arrow>
        
        <use xlink:href="/static/img/sprite.svg#expand_more" />
    </svg>


                            

        
    
        
            </button>
        



                            <!-- Login dropdown menu -->
                            <ul class="usa-nav__submenu ncbi-header__login-dropdown-menu"
                                id="login-dropdown-menu"
                                data-desktop-login-menu-dropdown
                                hidden>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        








<a href="https://www.ncbi.nlm.nih.gov/myncbi/" class="usa-link  "  >
    

    Dashboard

    
</a>

                                    </li>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        








<a href="https://www.ncbi.nlm.nih.gov/myncbi/collections/bibliography/" class="usa-link  "  >
    

    Publications

    
</a>

                                    </li>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        








<a href="https://www.ncbi.nlm.nih.gov/account/settings/" class="usa-link  "  >
    

    Account settings

    
</a>

                                    </li>
                                
                                <li class="usa-nav__submenu-item">
                                    



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--outline ncbi-header__login-dropdown-logout-button
           "
    
    
    
    data-testid="desktopLogoutButton"
    data-desktop-logout-button
    >
    
        

        Log out

        
    
        
            </button>
        


                                </li>
                            </ul>
                        </div>
                    
                </div>
            
        </div>
    </div>

    <!-- Search panel -->
    
        <div class="ncbi-search-panel ncbi--show-only-at-desktop"
             data-testid="searchPanel"
             data-header-search-panel
             hidden>
            <div class="ncbi-search-panel__container">
                <form action="https://www.ncbi.nlm.nih.gov/search/all/"
                      aria-describedby="search-field-desktop-navigation-help-text"
                      autocomplete="off"
                      class="usa-search usa-search--big ncbi-search-panel__form"
                      data-testid="form"
                      method="GET"
                      role="search">
                    <label class="usa-sr-only"
                           data-testid="label"
                           for="search-field-desktop-navigation">
                        Searchâ€¦
                    </label>
                    <input class="usa-input"
                           data-testid="textInput"
                           id="search-field-desktop-navigation"
                           name="term"
                           
                               placeholder="Search NCBI"
                           
                           type="search"
                           value="" />
                    



















    
        <button
            type="submit"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    
    data-testid="button"
    
    >
    
        

        
                        <span class="usa-search__submit-text">
                            Search NCBI
                        </span>
                    

        
    
        
            </button>
        


                </form>

                
            </div>
        </div>
    

    <nav aria-label="Primary navigation" class="usa-nav">
        <p class="usa-sr-only" id="primary-navigation-sr-only-title">
            Primary site navigation
        </p>

        <!-- Mobile menu close button -->
        



















    
        <button
            type="button"
        
    
    class="usa-nav__close ncbi-nav__close-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    aria-label="Close navigation menu"
    data-testid="navCloseButton"
    
    >
    
        

        
            <img src="/static/img/usa-icons/close.svg" alt="Close" />
        

        
    
        
            </button>
        



        
            <!-- Mobile search component -->
            <form class="usa-search usa-search--small ncbi--hide-at-desktop margin-top-6"
                  role="search">
                <label class="usa-sr-only" for="search-field">
                    Search
                </label>

                <input class="usa-input"
                       id="search-field-mobile-navigation"
                       type="search"
                       
                           placeholder="Search NCBI"
                       
                       name="search" />

                



















    
        <button
            type="submit"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    
    
    
    >
    
        

        
                    <!-- This SVG should be kept inline and not replaced with a link to the icon as otherwise it will render in the wrong color -->
                    <img src="data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIGhlaWdodD0iMjQiIHZpZXdCb3g9IjAgMCAyNCAyNCIgd2lkdGg9IjI0Ij48cGF0aCBkPSJNMCAwaDI0djI0SDB6IiBmaWxsPSJub25lIi8+PHBhdGggZmlsbD0iI2ZmZiIgZD0iTTE1LjUgMTRoLS43OWwtLjI4LS4yN0E2LjQ3MSA2LjQ3MSAwIDAgMCAxNiA5LjUgNi41IDYuNSAwIDEgMCA5LjUgMTZjMS42MSAwIDMuMDktLjU5IDQuMjMtMS41N2wuMjcuMjh2Ljc5bDUgNC45OUwyMC40OSAxOWwtNC45OS01em0tNiAwQzcuMDEgMTQgNSAxMS45OSA1IDkuNVM3LjAxIDUgOS41IDUgMTQgNy4wMSAxNCA5LjUgMTEuOTkgMTQgOS41IDE0eiIvPjwvc3ZnPg=="
                         class="usa-search__submit-icon"
                         alt="Search" />
                

        
    
        
            </button>
        


            </form>

            
        

        <!-- Primary navigation menu items -->
        <!-- This usa-nav__inner wrapper is required to correctly style the navigation items on Desktop -->
        

        
            <div class="ncbi-nav__mobile-login-menu ncbi--hide-at-desktop"
                 data-mobile-login-menu
                 hidden>
                <p class="ncbi-nav__mobile-login-menu-status">
                    Logged in as:
                    <strong class="ncbi-nav__mobile-login-menu-email"
                            data-mobile-login-email-text></strong>
                </p>
                <ul class="usa-nav__primary usa-accordion">
                    
                        <li class="usa-nav__primary-item">
                            








<a href="https://www.ncbi.nlm.nih.gov/myncbi/" class="usa-link  "  >
    

    Dashboard

    
</a>

                        </li>
                    
                        <li class="usa-nav__primary-item">
                            








<a href="https://www.ncbi.nlm.nih.gov/myncbi/collections/bibliography/" class="usa-link  "  >
    

    Publications

    
</a>

                        </li>
                    
                        <li class="usa-nav__primary-item">
                            








<a href="https://www.ncbi.nlm.nih.gov/account/settings/" class="usa-link  "  >
    

    Account settings

    
</a>

                        </li>
                    
                </ul>
            </div>
        

        



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           ncbi-nav__mobile-login-button ncbi--hide-at-desktop
           "
    
    
    
    data-testid="mobileLoginButton"
    data-mobile-login-button
    >
    
        

        Log in

        
    
        
            </button>
        


    </nav>
</header>

    
    
        

<section class="pmc-header pmc-header--basic" aria-label="PMC Header with search box">
    <div class="pmc-nav-container">
        <div class="pmc-header__bar">
           <div class="pmc-header__logo">
               <a href="/" title="Home" aria-label="PMC Home"></a>
           </div>
            <button
                    type="button"
                    class="usa-button usa-button--unstyled pmc-header__search__button"
                    aria-label="Open search"
                    data-ga-category="search"
                    data-ga-action="PMC"
                    data-ga-label="pmc_search_panel_mobile"
            >
                <svg class="usa-icon width-4 height-4 pmc-icon__open" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#search"></use>
                </svg>
                <svg class="usa-icon width-4 height-4 pmc-icon__close" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#close"></use>
                </svg>
            </button>
        </div>
        <div class="pmc-header__search">
            


<form class="usa-search usa-search--extra usa-search--article-right-column  pmc-header__search__form" id="pmc-search-form" autocomplete="off" role="search">
<label class="usa-sr-only" for="pmc-search">Search PMC Full-Text Archive</label>
<span class="autoComplete_wrapper flex-1">
<input class="usa-input width-full maxw-none" required="required" placeholder="Search PMC Full-Text Archive" id="pmc-search"  type="search" name="term" data-autocomplete-url="https://pmc.ncbi.nlm.nih.gov/autocomp/search/autocomp/"/>
</span>
<button
class="usa-button"
type="submit"
formaction="https://www.ncbi.nlm.nih.gov/pmc/"
data-ga-category="search"
data-ga-action="PMC"
data-ga-label="PMC_search_button"
>
<span class="usa-search__submit-text">Search in PMC</span>
<img
src="/static/img/usa-icons-bg/search--white.svg"
class="usa-search__submit-icon"
alt="Search"
/>
</button>
</form>
            <div class="display-flex flex-column tablet:flex-row tablet:flex-justify flex-justify-center flex-align-center width-full desktop:maxw-44">
                <ul class="pmc-header__search__menu">
                    <li>
                        <a class="usa-link" href="https://www.ncbi.nlm.nih.gov/pmc/advanced/" data-ga-action="featured_link" data-ga-label="advanced_search">
                            Advanced Search
                        </a>
                    </li>
                    <li>
                        
                            <a class="usa-link" href="/journals/" data-ga-action="featured_link" data-ga-label="journal list">
                                Journal List
                            </a>
                        
                    </li>
                    <li>
                        
                            <a class="usa-link" href="/about/userguide/" data-ga-action="featured_link"
                            data-ga-label="user guide">
                                User Guide
                            </a>
                        
                    </li>
                </ul>
                
                    <button form="pmc-search-form" formaction="https://pmc.ncbi.nlm.nih.gov/search/" type="submit" class="usa-button usa-button--unstyled hover:text-no-underline text-no-underline width-auto margin-top-1 tablet:margin-top-0">
     <span class="bg-green-label padding-05 text-white">New</span><span class="text-underline text-primary">Try this search in PMC Beta Search</span>
</button>
                
            </div>
        </div>
    </div>
</section>

    


        
        

       
  <div class="usa-section padding-top-0 desktop:padding-top-6 pmc-article-section" data-article-db="pmc" data-article-id="12335500">

    

   



<div class="grid-container pmc-actions-bar" aria-label="Actions bar" role="complementary">
    <div class="grid-row">
        <div class="grid-col-fill display-flex">
             <div class="display-flex">
                <ul class="usa-list usa-list--unstyled usa-list--horizontal">
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex mob">
                        <button
                                type="button"
                                class="usa-button pmc-sidenav__container__open usa-button--unstyled width-auto display-flex"
                                aria-label="Open resources"
                                data-extra-class="is-visible-resources"
                                data-ga-category="resources_accordion"
                                data-ga-action="click"
                                data-ga-label="mobile_icon"
                        >
                            <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                <use xlink:href="/static/img/sprite.svg#more_vert"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex mob">
                        <a
                                href="https://doi.org/10.1038/s41419-025-07929-x"
                                class="usa-link display-flex usa-tooltip"
                                role="button"
                                target="_blank"
                                rel="noreferrer noopener"
                                title="View on publisher site"
                                data-position="bottom"
                                aria-label="View on publisher site"
                                data-ga-category="actions"
                                data-ga-action="click"
                                data-ga-label="publisher_link_mobile"
                        >
                                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                    <use xlink:href="/static/img/sprite.svg#launch"></use>
                                </svg>
                        </a>
                    </li>
                    
                    
                        <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                             <a
                                     href="pdf/41419_2025_Article_7929.pdf"
                                     class="usa-link display-flex usa-tooltip"
                                     role="button"
                                     title="Download PDF"
                                     data-position="bottom"
                                     aria-label="Download PDF"
                                     data-ga-category="actions"
                                     data-ga-action="click"
                                     data-ga-label="pdf_download_mobile"
                             >
                                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                    <use xlink:href="/static/img/sprite.svg#file_download"></use>
                                </svg>
                            </a>
                        </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                        <button
                            class="usa-button usa-button--unstyled  usa-tooltip collections-dialog-trigger collections-button display-flex collections-button-empty"
                            title="Add to Collections"
                            data-position="bottom"
                            aria-label="Save article in MyNCBI collections."
                            data-ga-category="actions"
                            data-ga-action="click"
                            data-ga-label="collections_button_mobile"
                            data-collections-open-dialog-enabled="false"
                            data-collections-open-dialog-url="https://account.ncbi.nlm.nih.gov/?back_url=https%3A%2F%2Fpmc.ncbi.nlm.nih.gov%2Farticles%2FPMC12335500%2F%3Freport%3Dclassic%23open-collections-dialog"
                            data-in-collections="false"
                        >
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-full" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-full.svg#icon"></use>
                            </svg>
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-empty.svg#icon"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                        <button role="button" class="usa-button usa-button--unstyled usa-tooltip citation-dialog-trigger display-flex"
                            aria-label="Open dialog with citation text in different styles"
                            title="Cite"
                            data-position="bottom"
                            data-ga-category="actions"
                            data-ga-action="open"
                            data-ga-label="cite_mobile"
                            data-all-citations-url="/resources/citations/12335500/"
                            data-citation-style="nlm"
                            data-download-format-link="/resources/citations/12335500/export/"
                        >
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/sprite.svg#format_quote"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="pmc-permalink display-flex" >
                         <button
                                 type="button"
                                 title="Permalink"
                                 data-position="bottom"
                                 class="usa-button usa-button--unstyled display-flex usa-tooltip"
                                 aria-label="Show article permalink"
                                 aria-expanded="false"
                                 aria-haspopup="true"
                                 data-ga-category="actions"
                                 data-ga-action="open"
                                 data-ga-label="permalink_mobile"
                         >
                            <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                <use xlink:href="/static/img/sprite.svg#share"></use>
                            </svg>
                        </button>
                        

<div class="pmc-permalink__dropdown" hidden>
    <div class="pmc-permalink__dropdown__container">
          <h2 class="usa-modal__heading margin-top-0 margin-bottom-2 text-uppercase font-sans-xs">PERMALINK</h2>
          <div class="pmc-permalink__dropdown__content">
              <input type="text" class="usa-input" value="https://pmc.ncbi.nlm.nih.gov/articles/PMC12335500/" aria-label="Article permalink">
              <button class="usa-button display-inline-flex pmc-permalink__dropdown__copy__btn margin-right-0" title="Copy article permalink" data-ga-category="save_share" data-ga-action="link" data-ga-label="copy_link">
                  <svg class="usa-icon" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#content_copy"></use>
                  </svg>
                  <span class="margin-left-1">Copy</span>
              </button>
          </div>
    </div>
</div>
                    </li>
                </ul>
            </div>
            <button
                    type="button"
                    class="usa-button pmc-sidenav__container__open usa-button--unstyled width-auto display-flex"
                    aria-label="Open article navigation"
                    data-extra-class="is-visible-in-page"
                    data-ga-category="actions"
                    data-ga-action="open"
                    data-ga-label="article_nav_mobile"
            >
                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#list"></use>
                </svg>
            </button>
        </div>
    </div>
</div>
    <div class="grid-container desktop:padding-left-6">
      <div id="article-container" class="grid-row grid-gap">
        <div class="grid-col-12 desktop:grid-col-8 order-2 pmc-layout__content">
            <div class="grid-container padding-left-0 padding-right-0">
                <div class="grid-row desktop:margin-left-neg-6">
                    <div class="grid-col-12">
                        <div class="pmc-layout__disclaimer" role="complementary" aria-label="Disclaimer note">
    As a library, NLM provides access to scientific literature. Inclusion in an NLM database does not imply endorsement of, or agreement with,
    the contents by NLM or the National Institutes of Health.<br/>
    Learn more:
    <a class="usa-link" data-ga-category="Link click" data-ga-action="Disclaimer" data-ga-label="New disclaimer box" href="/about/disclaimer/">PMC Disclaimer</a>
    |
    <a class="usa-link" data-ga-category="Link click" data-ga-action="PMC Copyright Notice" data-ga-label="New disclaimer box" href="/about/copyright/">
        PMC Copyright Notice
    </a>
</div>
                    </div>
                </div>
                <div class="grid-row pmc-wm desktop:margin-left-neg-6">
                    <!-- Main content -->
                    <main
                      id="main-content"
                      class="usa-layout-docs__main usa-layout-docs grid-col-12 pmc-layout pmc-prose padding-0"
                    >

                      
                        <section class="pmc-journal-banner text-center line-height-none" aria-label="Journal banner"><img src="https://cdn.ncbi.nlm.nih.gov/pmc/banners/logo-cddis.gif" alt="Cell Death &amp; Disease logo" usemap="#pmc-banner-imagemap" width="500" height="75"><map name="pmc-banner-imagemap"><area alt="Link to Cell Death &amp; Disease" title="Link to Cell Death &amp; Disease" shape="default" href="http://www.nature.com/cddis/" target="_blank" rel="noopener noreferrer"></map></section><article lang="en"><section aria-label="Article citation and metadata"><section class="pmc-layout__citation font-secondary font-xs"><div>
<div class="display-inline-block"><button type="button" class="cursor-pointer text-no-underline bg-transparent border-0 padding-0 text-left margin-0 text-normal text-primary" aria-controls="journal_context_menu">Cell Death Dis</button></div>. 2025 Aug 10;16(1):605. doi: <a href="https://doi.org/10.1038/s41419-025-07929-x" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">10.1038/s41419-025-07929-x</a>
</div>
<nav id="journal_context_menu" hidden="hidden"><ul class="menu-list font-family-ui" role="menu">
<li role="presentation"><a href="https://www.ncbi.nlm.nih.gov/pmc/?term=%22Cell%20Death%20Dis%22%5Bjour%5D" class="usa-link" role="menuitem">Search in PMC</a></li>
<li role="presentation"><a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Cell%20Death%20Dis%22%5Bjour%5D" lang="en" class="usa-link" role="menuitem">Search in PubMed</a></li>
<li role="presentation"><a href="https://www.ncbi.nlm.nih.gov/nlmcatalog?term=%22Cell%20Death%20Dis%22%5BTitle%20Abbreviation%5D" class="usa-link" role="menuitem">View in NLM Catalog</a></li>
<li role="presentation"><a href="?term=%22Cell%20Death%20Dis%22%5Bjour%5D" class="usa-link" role="menuitem" data-add-to-search="true">Add to search</a></li>
</ul></nav></section><section class="front-matter"><div class="ameta p font-secondary font-xs">
<hgroup><h1>EPS8L2 drives colorectal cancer cell proliferation and migration via YBX1-dependent activation of G3BP2 transcription</h1></hgroup><div class="cg p">
<a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Duan%20Y%22%5BAuthor%5D" class="usa-link" aria-describedby="id1"><span class="name western">Yimeng Duan</span></a><div hidden="hidden" id="id1">
<h3><span class="name western">Yimeng Duan</span></h3>
<div class="p">
<sup>1</sup>State Key Laboratory of Metabolic Dysregulation &amp; Prevention and Treatment of Esophageal Cancer, Tianjian Laboratory of Advanced Biomedical Sciences, Academy of Medical Sciences, Zhengzhou University, Zhengzhou, China </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Duan%20Y%22%5BAuthor%5D" class="usa-link"><span class="name western">Yimeng Duan</span></a>
</div>
</div>
<sup>1,</sup><sup>#</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Li%20P%22%5BAuthor%5D" class="usa-link" aria-describedby="id2"><span class="name western">Peixian Li</span></a><div hidden="hidden" id="id2">
<h3><span class="name western">Peixian Li</span></h3>
<div class="p">
<sup>1</sup>State Key Laboratory of Metabolic Dysregulation &amp; Prevention and Treatment of Esophageal Cancer, Tianjian Laboratory of Advanced Biomedical Sciences, Academy of Medical Sciences, Zhengzhou University, Zhengzhou, China </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Li%20P%22%5BAuthor%5D" class="usa-link"><span class="name western">Peixian Li</span></a>
</div>
</div>
<sup>1,</sup><sup>#</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Yang%20Y%22%5BAuthor%5D" class="usa-link" aria-describedby="id3"><span class="name western">Yanmei Yang</span></a><div hidden="hidden" id="id3">
<h3><span class="name western">Yanmei Yang</span></h3>
<div class="p">
<sup>1</sup>State Key Laboratory of Metabolic Dysregulation &amp; Prevention and Treatment of Esophageal Cancer, Tianjian Laboratory of Advanced Biomedical Sciences, Academy of Medical Sciences, Zhengzhou University, Zhengzhou, China </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Yang%20Y%22%5BAuthor%5D" class="usa-link"><span class="name western">Yanmei Yang</span></a>
</div>
</div>
<sup>1</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Wu%20G%22%5BAuthor%5D" class="usa-link" aria-describedby="id4"><span class="name western">Guanghua Wu</span></a><div hidden="hidden" id="id4">
<h3><span class="name western">Guanghua Wu</span></h3>
<div class="p">
<sup>1</sup>State Key Laboratory of Metabolic Dysregulation &amp; Prevention and Treatment of Esophageal Cancer, Tianjian Laboratory of Advanced Biomedical Sciences, Academy of Medical Sciences, Zhengzhou University, Zhengzhou, China </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Wu%20G%22%5BAuthor%5D" class="usa-link"><span class="name western">Guanghua Wu</span></a>
</div>
</div>
<sup>1</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Xing%20H%22%5BAuthor%5D" class="usa-link" aria-describedby="id5"><span class="name western">Hao Xing</span></a><div hidden="hidden" id="id5">
<h3><span class="name western">Hao Xing</span></h3>
<div class="p">
<sup>1</sup>State Key Laboratory of Metabolic Dysregulation &amp; Prevention and Treatment of Esophageal Cancer, Tianjian Laboratory of Advanced Biomedical Sciences, Academy of Medical Sciences, Zhengzhou University, Zhengzhou, China </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Xing%20H%22%5BAuthor%5D" class="usa-link"><span class="name western">Hao Xing</span></a>
</div>
</div>
<sup>1</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Chen%20H%22%5BAuthor%5D" class="usa-link" aria-describedby="id6"><span class="name western">Hong Chen</span></a><div hidden="hidden" id="id6">
<h3><span class="name western">Hong Chen</span></h3>
<div class="p">
<sup>1</sup>State Key Laboratory of Metabolic Dysregulation &amp; Prevention and Treatment of Esophageal Cancer, Tianjian Laboratory of Advanced Biomedical Sciences, Academy of Medical Sciences, Zhengzhou University, Zhengzhou, China </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Chen%20H%22%5BAuthor%5D" class="usa-link"><span class="name western">Hong Chen</span></a>
</div>
</div>
<sup>1</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Zhao%20L%22%5BAuthor%5D" class="usa-link" aria-describedby="id7"><span class="name western">Liangbo Zhao</span></a><div hidden="hidden" id="id7">
<h3><span class="name western">Liangbo Zhao</span></h3>
<div class="p">
<sup>1</sup>State Key Laboratory of Metabolic Dysregulation &amp; Prevention and Treatment of Esophageal Cancer, Tianjian Laboratory of Advanced Biomedical Sciences, Academy of Medical Sciences, Zhengzhou University, Zhengzhou, China </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Zhao%20L%22%5BAuthor%5D" class="usa-link"><span class="name western">Liangbo Zhao</span></a>
</div>
</div>
<sup>1</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Liu%20L%22%5BAuthor%5D" class="usa-link" aria-describedby="id8"><span class="name western">Lei Liu</span></a><div hidden="hidden" id="id8">
<h3><span class="name western">Lei Liu</span></h3>
<div class="p">
<sup>2</sup>Department of Pathophysiology, School of Basic Medical Sciences, Zhengzhou University, Zhengzhou, China </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Liu%20L%22%5BAuthor%5D" class="usa-link"><span class="name western">Lei Liu</span></a>
</div>
</div>
<sup>2</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Sun%20X%22%5BAuthor%5D" class="usa-link" aria-describedby="id9"><span class="name western">Xiao Sun</span></a><div hidden="hidden" id="id9">
<h3><span class="name western">Xiao Sun</span></h3>
<div class="p">
<sup>1</sup>State Key Laboratory of Metabolic Dysregulation &amp; Prevention and Treatment of Esophageal Cancer, Tianjian Laboratory of Advanced Biomedical Sciences, Academy of Medical Sciences, Zhengzhou University, Zhengzhou, China </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Sun%20X%22%5BAuthor%5D" class="usa-link"><span class="name western">Xiao Sun</span></a>
</div>
</div>
<sup>1</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Jin%20S%22%5BAuthor%5D" class="usa-link" aria-describedby="id10"><span class="name western">Shuiling Jin</span></a><div hidden="hidden" id="id10">
<h3><span class="name western">Shuiling Jin</span></h3>
<div class="p">
<sup>3</sup>Department of Oncology, the First Affiliated Hospital of Zhengzhou University, Zhengzhou, China </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Jin%20S%22%5BAuthor%5D" class="usa-link"><span class="name western">Shuiling Jin</span></a>
</div>
</div>
<sup>3,</sup><sup>âœ‰</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22He%20L%22%5BAuthor%5D" class="usa-link" aria-describedby="id11"><span class="name western">Luyun He</span></a><div hidden="hidden" id="id11">
<h3><span class="name western">Luyun He</span></h3>
<div class="p">
<sup>2</sup>Department of Pathophysiology, School of Basic Medical Sciences, Zhengzhou University, Zhengzhou, China </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22He%20L%22%5BAuthor%5D" class="usa-link"><span class="name western">Luyun He</span></a>
</div>
</div>
<sup>2,</sup><sup>âœ‰</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Liu%20B%22%5BAuthor%5D" class="usa-link" aria-describedby="id12"><span class="name western">Benyu Liu</span></a><div hidden="hidden" id="id12">
<h3><span class="name western">Benyu Liu</span></h3>
<div class="p">
<sup>1</sup>State Key Laboratory of Metabolic Dysregulation &amp; Prevention and Treatment of Esophageal Cancer, Tianjian Laboratory of Advanced Biomedical Sciences, Academy of Medical Sciences, Zhengzhou University, Zhengzhou, China </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Liu%20B%22%5BAuthor%5D" class="usa-link"><span class="name western">Benyu Liu</span></a>
</div>
</div>
<sup>1,</sup><sup>âœ‰</sup>
</div>
<ul class="d-buttons inline-list">
<li><button class="d-button" aria-controls="aip_a" aria-expanded="false">Author information</button></li>
<li><button class="d-button" aria-controls="anp_a" aria-expanded="false">Article notes</button></li>
<li><button class="d-button" aria-controls="clp_a" aria-expanded="false">Copyright and License information</button></li>
</ul>
<div class="d-panels font-secondary-light">
<div id="aip_a" class="d-panel p" style="display: none">
<div class="p" id="Aff1">
<sup>1</sup>State Key Laboratory of Metabolic Dysregulation &amp; Prevention and Treatment of Esophageal Cancer, Tianjian Laboratory of Advanced Biomedical Sciences, Academy of Medical Sciences, Zhengzhou University, Zhengzhou, China </div>
<div id="Aff2">
<sup>2</sup>Department of Pathophysiology, School of Basic Medical Sciences, Zhengzhou University, Zhengzhou, China </div>
<div id="Aff3">
<sup>3</sup>Department of Oncology, the First Affiliated Hospital of Zhengzhou University, Zhengzhou, China </div>
<div class="author-notes p">
<div class="fn" id="_fncrsp93pmc__">
<sup>âœ‰</sup><p class="display-inline">Corresponding author.</p>
</div>
<div class="fn" id="_eqcntrb93pmc__">
<sup>#</sup><p class="display-inline">Contributed equally.</p>
</div>
</div>
</div>
<div id="anp_a" class="d-panel p" style="display: none"><div class="notes p"><section id="historyarticle-meta1" class="history"><p>Received 2025 Feb 13; Revised 2025 Jun 29; Accepted 2025 Jul 30; Collection date 2025 Dec.</p></section></div></div>
<div id="clp_a" class="d-panel p" style="display: none">
<div>Â© The Author(s) 2025</div>
<p><strong>Open Access</strong> This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the articleâ€™s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the articleâ€™s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit <a href="https://creativecommons.org/licenses/by/4.0/" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">http://creativecommons.org/licenses/by/4.0/</a>.</p>
<div class="p"><a href="/about/copyright/" class="usa-link">PMC Copyright notice</a></div>
</div>
</div>
<div>PMCID: PMC12335500Â Â PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/40783393/" class="usa-link">40783393</a>
</div>
</div></section></section><section aria-label="Article content"><section class="body main-article-body"><section class="abstract" id="Abs1"><h2>Abstract</h2>
<p id="Par1">Colorectal cancer (CRC) remains a leading cause of cancer-related mortality worldwide, characterized by molecular heterogeneity and limited therapeutic options. Here, we identified EPS8L2 as a novel driver of colorectal tumorigenesis. EPS8L2 is significantly upregulated in CRC tissues and negatively correlated with patientsâ€™ prognosis. Functionally, upregulation of EPS8L2 promotes proliferation and metastasis of CRC cells in vitro and in vivo, and vice versa. Similarly, EPS8L2 overexpression promotes patient-derived organoids growth. Mechanistically, EPS8L2 increases YBX1 phosphorylation by enhancing its interaction with phosphokinase S6K1. Phosphorylated YBX1 translocates into nucleus and initiates G3BP2 transcription, leading to activation of the MAPK signaling pathway. Moreover, knockout of <em>Eps8l2</em> impairs CRC tumorigenesis in the AOM/DSS induced mouse model. In summary, we revealed a novel EPS8L2-YBX1-G3BP2 regulatory axis involved in CRC progression, which provides a new theoretical basis for tumor therapy.</p>
<section id="kwd-group1" class="kwd-group"><p><strong>Subject terms:</strong> Oncogenes, Mechanisms of disease</p></section></section><section id="Sec1"><h2 class="pmc_sec_title">Introduction</h2>
<p id="Par2">Colorectal cancer (CRC), including both colon and rectal cancers, ranks as the second leading cause of cancer-related deaths [<a href="#CR1" class="usa-link" aria-describedby="CR1">1</a>]. Its pathogenesis typically initiates cumulative genetic and epigenetic alterations in colonic epithelium, driving aberrant cellular proliferation and malignant transformation [<a href="#CR2" class="usa-link" aria-describedby="CR2">2</a>]. While early detection programs have improved 5-year survival rates, ~25% of patients present with stage IV disease at diagnosis, and an additional 25â€“50% of initially early-stage patients progress to metastatic CRC [<a href="#CR3" class="usa-link" aria-describedby="CR3">3</a>]. The prognosis of metastatic CRC patients remains poor, with a median 5-year survival rate of only 12.5% [<a href="#CR4" class="usa-link" aria-describedby="CR4">4</a>]. Therapeutic strategies diverge significantly by disease stage. Surgical resection is the preferred treatment option for early-stage CRC, while advanced or recurrent CRC typically requires multidisciplinary approach, combining chemotherapy, targeted therapy, and immunotherapy [<a href="#CR5" class="usa-link" aria-describedby="CR5">5</a>]. Despite therapeutic advances, metastasis and recurrence persist as principal barriers to survival improvement. Consequently, deciphering the molecular drivers of CRC progression and identifying specific biomarkers are critical imperatives for enhancing the prognosis of CRC patients.</p>
<p id="Par3">Receptor tyrosine kinases (RTKs) are critical transmembrane receptors responsible for transmitting extracellular signals into intracellular [<a href="#CR6" class="usa-link" aria-describedby="CR6">6</a>]. They regulate essential processes like cell growth, differentiation, and survival [<a href="#CR7" class="usa-link" aria-describedby="CR7">7</a>], making them important targets for cancer therapy [<a href="#CR8" class="usa-link" aria-describedby="CR8">8</a>]. Among RTK family, the epidermal growth factor receptor (EGFR) is particularly well-studied in cancer. When activated by ligands (e.g., EGF), EGFR triggers key pathways including RAS-RAF-MAPK and PI3K-AKT, which drive cancer cell proliferation and metastasis [<a href="#CR9" class="usa-link" aria-describedby="CR9">9</a>, <a href="#CR10" class="usa-link" aria-describedby="CR10">10</a>]. Therefore, exploring and understanding the functions and mechanisms of RTK-related genes remains crucial for developing better CRC treatments and understanding disease mechanisms.</p>
<p id="Par4">EPS8, a conserved intracellular substrate of the EGFR pathway, is widely expressed across species, including humans, nematodes, and fruit flies [<a href="#CR11" class="usa-link" aria-describedby="CR11">11</a>]. The EPS8 protein family comprises four structurally homologous members (EPS8, EPS8L1, EPS8L2, and EPS8L3), all sharing key functional domains: an N-terminal phosphotyrosine-binding (PTB) domain, central SH3 domain, and C-terminal effector region [<a href="#CR12" class="usa-link" aria-describedby="CR12">12</a>]. Members of the EPS8 family have been widely reported to be closely associated with various cancers [<a href="#CR13" class="usa-link" aria-describedby="CR13">13</a>â€“<a href="#CR15" class="usa-link" aria-describedby="CR15">15</a>]. Current studies about EPS8L2 primarily focused on auditory system [<a href="#CR16" class="usa-link" aria-describedby="CR16">16</a>â€“<a href="#CR18" class="usa-link" aria-describedby="CR18">18</a>], where its loss causes hearing impairment [<a href="#CR16" class="usa-link" aria-describedby="CR16">16</a>, <a href="#CR17" class="usa-link" aria-describedby="CR17">17</a>]. EPS8L2 has also been reported to be involved in cytoskeletal reorganization, urinary extracellular vesicle production, and nuclear movement during cell migration [<a href="#CR19" class="usa-link" aria-describedby="CR19">19</a>â€“<a href="#CR21" class="usa-link" aria-describedby="CR21">21</a>]. Moreover, EPS8L2 is associated with T cell activation, lupus nephritis, and diabetic erectile dysfunction [<a href="#CR22" class="usa-link" aria-describedby="CR22">22</a>â€“<a href="#CR24" class="usa-link" aria-describedby="CR24">24</a>]. In cancer, EPS8L2 was reported to be associated with testicular germ cell tumorsâ€™ drug resistance [<a href="#CR25" class="usa-link" aria-describedby="CR25">25</a>]. Additionally, high expression of EPS8L2 is a biomarker of endometrial carcinoma, renal cell carcinoma, and rhabdomyosarcoma [<a href="#CR26" class="usa-link" aria-describedby="CR26">26</a>â€“<a href="#CR28" class="usa-link" aria-describedby="CR28">28</a>]. However, the function and mechanism of EPS8L2 in CRC development remain unknown.</p>
<p id="Par5">Here, we identified EPS8L2 was upregulated in CRC through bioinformatics analysis and CRC tissue microarray. We found that elevated EPS8L2 expression was significantly associated with tumor grade, lymph node metastasis, and CRC patientsâ€™ poor prognosis. Additionally, we showed that EPS8L2 promoted CRC cell proliferation and metastasis by facilitating S6K1-mediated YBX1 phosphorylation and subsequent nuclear translocation to activate G3BP2 transcription and the MAPK signaling pathway. Furthermore, <em>Eps8l2</em> knockout led to decreased tumor incidence in an AOM/DSS-induced carcinogenesis model. Altogether, this study elucidated a previously unknown biological function and mechanism of EPS8L2 in CRC, which may provide a promising treatment strategy for CRC intervention.</p></section><section id="Sec2"><h2 class="pmc_sec_title">Results</h2>
<section id="Sec3"><h3 class="pmc_sec_title">EPS8L2 is upregulated in CRC</h3>
<p id="Par6">To explore potential regulators involved in CRC development, we compared gene expression profiles in several publicly accessible human CRC datasets from the Cancer Genome Atlas (TCGA) and the Gene Expression Omnibus (GEO) databases. We identified 665 overlapping differentially expressed genes (DEGs) based on a significant threshold of |log<sub>2</sub>FC|â€‰â‰¥â€‰0.58 and <em>p</em>â€‰&lt;â€‰0.05 (Fig. <a href="#Fig1" class="usa-link">1A, B</a>). We then performed Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) enrichment analysis using the 665 common DEGs and found that the RTK signaling was significantly enriched, such as ERK1 and ERK2 cascade, and PI3K-AKT signaling pathway (Fig. <a href="#Fig1" class="usa-link">1C, D</a>). Therefore, we focused on RTK-related genes and analyzed their expression changes in CRC tissues compared to normal controls (Fig. <a href="#Fig1" class="usa-link">1E</a> and Supplementary Fig. <a href="#MOESM1" class="usa-link">1A</a>). The thirty most upregulated genes in CRC tissues were analyzed, and only EPS8L2â€™s function in CRC remains unclear. We therefore selected EPS8L2 for following exploration. The upregulation of EPS8L2 mRNA and protein levels in CRC was further validated (Fig. <a href="#Fig1" class="usa-link">1Fâ€“H</a>). We then obtained a human CRC tissue microarray (TMA) and verified that EPS8L2 was highly expressed in tumor tissues compared with paired peri-tumor tissues (Fig. <a href="#Fig1" class="usa-link">1I</a>). In addition, EPS8L2 expression level was increased in CRC samples with III and IV clinical stages (Fig. <a href="#Fig1" class="usa-link">1J</a>) or lymph node metastasis (Fig. <a href="#Fig1" class="usa-link">1K</a> and Supplementary Fig. <a href="#MOESM1" class="usa-link">1B</a>). Moreover, high expression of EPS8L2 was associated with poor prognosis (Fig. <a href="#Fig1" class="usa-link">1L</a> and Supplementary Fig. <a href="#MOESM1" class="usa-link">1C</a>). Conclusively, EPS8L2 is highly expressed in CRC and positively correlated with poor prognosis.</p>
<figure class="fig xbox font-sm" id="Fig1"><h4 class="obj_head">Fig. 1. EPS8L2 is upregulated in CRC.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12335500_41419_2025_7929_Fig1_HTML.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5684/12335500/277d946eac3f/41419_2025_7929_Fig1_HTML.jpg" loading="lazy" id="d33e481" height="999" width="765" alt="Fig. 1"></a></p>
<div class="p text-right font-secondary"><a href="figure/Fig1/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p><strong>A</strong>, <strong>B</strong> DEGs in TCGA+GTEx, <a href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE103512" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">GSE103512</a>, and <a href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE75970" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">GSE75970</a> datasets were illustrated using volcano plots (<strong>A</strong>) and venn diagram (<strong>B</strong>). <strong>C, D</strong> GO (<strong>C</strong>) and KEGG (<strong>D</strong>) enrichment analysis of 665 common DEGs in (<strong>B</strong>). <strong>E</strong> 104 upregulated RTK related genes among three datasets were displayed by heatmap. <strong>F</strong> EPS8L2 expression in COAD and READ according to GEPIA website. COAD: colon adenocarcinoma, READ: rectal adenocarcinoma. Boxplot lower boundary represents the first quartile, the upper boundary represents the third quartile, and the median is indicated by solid horizontal line. <strong>G</strong> EPS8L2 expression in 15 pairs of CRC samples was examined by RT-qPCR. <strong>H</strong> EPS8L2 expression was detected by IHC staining in 5 pairs of CRC samples. Scale bars, 100â€‰Î¼m. Representative images were shown in left panel, and statistical results of IHC score were shown in right panel. <strong>I</strong>â€“<strong>K</strong> EPS8L2 expression was detected by IHC staining in CRC tissue array. Representative images of EPS8L2 expression in paired tissues (<strong>I</strong>), different pathological grading tissues (<strong>J</strong>), and lymph node metastasis tissues (<strong>K</strong>) were shown in left panel. The correspondingly statistical results of IHC score were shown in right panel by violin plots (<strong>I</strong>â€“<strong>K</strong>). The dashed lines indicate the median IHC score for each group. N0 represents patients without lymph node metastasis, and N1 represents patients with localized lymph node metastasis in (<strong>K</strong>). Scale bars, 500 Î¼m. <strong>L</strong> Relationship between EPS8L2 expression and CRC patientsâ€™ overall survival according to CRC tissue array. Data are presented as meansâ€‰Â±â€‰SD. ***<em>p</em>â€‰&lt;â€‰0.001, **<em>p</em>â€‰&lt;â€‰0.01, *<em>p</em>â€‰&lt;â€‰0.05.</p></figcaption></figure></section><section id="Sec4"><h3 class="pmc_sec_title">EPS8L2 promotes CRC cell proliferation and migration</h3>
<p id="Par7">To investigate its function, stable EPS8L2 knockdown cell lines were successfully established (Fig. <a href="#Fig2" class="usa-link">2A, B</a>). We found that EPS8L2 silencing markedly inhibited cell proliferation as shown by CCK-8 assay and colony formation assay (Fig. <a href="#Fig2" class="usa-link">2C, D</a>). Furthermore, transwell migration and wound healing assays were conducted and revealed that EPS8L2 knockdown reduced the migratory ability of HCT116 and HT29 cells (Fig. <a href="#Fig2" class="usa-link">2E, F</a>). Interestingly, knockdown of EPS8L2 resulted in increased apoptosis (Fig. <a href="#Fig2" class="usa-link">2G</a>), which was further validated by enhanced BAX expression and downregulation of BCL2 (Fig. <a href="#Fig2" class="usa-link">2H</a>). To explore its role in vivo, we subcutaneously implanted EPS8L2-depleted HCT116 cells into BALB/c nude mice. The results showed that EPS8L2 knockdown significantly decreased tumor volume and weight in nude mice (Fig. <a href="#Fig2" class="usa-link">2Iâ€“K</a>). Consistently, Ki67 expression was obviously inhibited after EPS8L2 knockdown (Fig. <a href="#Fig2" class="usa-link">2L</a>). We then performed an in vivo metastasis assay by injecting EPS8L2 knockdown (shEPS8L2) or control (shNC) HCT116 cells into the tail vein of BALB/c nude mice. We observed a significant reduction in liver metastatic nodules in shEPS8L2 group (Fig. <a href="#Fig2" class="usa-link">2M, N</a>).</p>
<figure class="fig xbox font-sm" id="Fig2"><h4 class="obj_head">Fig. 2. EPS8L2 knockdown inhibits CRC cell proliferation and migration.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12335500_41419_2025_7929_Fig2_HTML.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5684/12335500/f14e2b823c8f/41419_2025_7929_Fig2_HTML.jpg" loading="lazy" id="d33e603" height="835" width="790" alt="Fig. 2"></a></p>
<div class="p text-right font-secondary"><a href="figure/Fig2/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p><strong>A</strong>, <strong>B</strong> EPS8L2 expression were examined by RT-qPCR (<strong>A</strong>) and western blotting (<strong>B</strong>) in EPS8L2 knockdown HCT116 and HT29 cells. <strong>C, D</strong> Cell proliferation was measured using CCK-8 assay (<strong>C</strong>) and colony formation assay (<strong>D</strong>) after EPS8L2 knockdown in HCT116 and HT29 cells. <strong>E</strong>, <strong>F</strong> Transwell migration (<strong>E</strong>) and wound healing (<strong>F</strong>) assays were conducted to assess the migratory ability of HCT116 and HT29 cells after EPS8L2 knockdown. Scale bars, 100â€‰Î¼m. <strong>G</strong> FACS measured HCT116 and HT29 cell apoptotic rate after EPS8L2 knockdown. Representative images were shown in left panel and statistical results were shown in right panel. <strong>H</strong> Expression of EPS8L2, MMP9, MMP2, BAX, and BCL2 was detected by western blotting after EPS8L2 knockdown in HCT116 and HT29 cells. <strong>I</strong>â€“<strong>K</strong> EPS8L2 knockdown and control HCT116 cells were injected into BALB/c nude mice for 15 days (<em>n</em>â€‰=â€‰6 per group). Statistical results of tumor volumes (<strong>I</strong>), images of subcutaneous xenograft tumors (<strong>J</strong>), and statistical results of tumor weights (<strong>K</strong>) were shown. <strong>L</strong> Expression of EPS8L2 and Ki67 in subcutaneous xenograft tumors was detected by IHC staining. Scale bars, 100â€‰Î¼m. <strong>M, N</strong> EPS8L2 knockdown and control HCT116 cells were injected into tail vein of BALB/c nude mice for 33 days (<em>n</em>â€‰=â€‰4 per group). Representative images of liver metastasis nodules and HE staining (<strong>M</strong>) and quantification of liver metastatic nodules were shown (<strong>N</strong>). Scale bars, 500â€‰Î¼m. Data are presented as meansâ€‰Â±â€‰SD. ***<em>p</em>â€‰&lt;â€‰0.001, **<em>p</em>â€‰&lt;â€‰0.01, *<em>p</em>â€‰&lt;â€‰0.05.</p></figcaption></figure><p id="Par8">To further confirm above findings, we generated EPS8L2-overexpressing HCT116 and SW480 cell lines (Fig. <a href="#Fig3" class="usa-link">3A, B</a>). We found that EPS8L2 overexpression greatly enhanced the proliferation and migration capacities of HCT116 and SW480 cells in vitro (Fig. <a href="#Fig3" class="usa-link">3Câ€“F</a>). Importantly, the expression levels of epithelial-mesenchymal transition (EMT) markers, MMP2 and MMP9, were also significantly upregulated after EPS8L2 overexpression (Fig. <a href="#Fig3" class="usa-link">3G</a>). We also overexpressed EPS8L2 in RKO cells, which lacks endogenous EPS8L2 expression (Supplementary Fig. <a href="#MOESM1" class="usa-link">2A, B</a>). Consistently, EPS8L2 ectopic expression promoted RKO cell proliferation and migration in vitro (Supplementary Fig. <a href="#MOESM1" class="usa-link">2Câ€“E</a>). Next, xenograft and in vivo metastasis assays were carried out using EPS8L2 overexpressing HCT116 cells. The results indicated that EPS8L2 overexpression increased tumor volume and weight (Fig. <a href="#Fig3" class="usa-link">3Hâ€“J</a>). The upregulation of EPS8L2 in tumor tissues was validated by RT-qPCR, western blotting, and IHC (Fig. <a href="#Fig3" class="usa-link">3Kâ€“M</a>). Besides, MMP9, MMP2, and Ki67 expression levels were increased after EPS8L2 overexpression (Fig. <a href="#Fig3" class="usa-link">3L, M</a>). Similarly, we observed a significant increase in liver metastatic nodules in the oeEPS8L2 group after injecting HCT116 cells into the tail vein (Fig. <a href="#Fig3" class="usa-link">3N, O</a>). To further assess its preclinical relevance, we obtained fresh CRC samples and conducted patient-derived organoids (PDOs) experiments. We found that EPS8L2 overexpression promoted organoids growth (Fig. <a href="#Fig3" class="usa-link">3P</a>). Collectively, EPS8L2 promotes CRC cell proliferation and migration in vitro and in vivo.</p>
<figure class="fig xbox font-sm" id="Fig3"><h4 class="obj_head">Fig. 3. EPS8L2 overexpression promotes CRC cell growth and invasion.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12335500_41419_2025_7929_Fig3_HTML.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5684/12335500/add3ce2bc411/41419_2025_7929_Fig3_HTML.jpg" loading="lazy" id="d33e742" height="862" width="790" alt="Fig. 3"></a></p>
<div class="p text-right font-secondary"><a href="figure/Fig3/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p><strong>A</strong>, <strong>B</strong> EPS8L2 expression were examined by RT-qPCR (<strong>A</strong>) and western blotting (<strong>B</strong>) in EPS8L2 overexpression HCT116 and SW480 cells. <strong>C</strong>, <strong>D</strong> Cell proliferation was measured using CCK-8 assay (<strong>C</strong>) and colony formation assay (<strong>D</strong>) after EPS8L2 overexpression in HCT116 and SW480 cells. <strong>E</strong>, <strong>F</strong> Wound healing (<strong>E</strong>) and transwell migration (<strong>F</strong>) assays were conducted to assess the migratory ability of HCT116 and SW480 cells after EPS8L2 overexpression. Scale bars, 100â€‰Î¼m. Representative images were shown in left panel and statistical results were shown in right panel. <strong>G</strong> Expression of EPS8L2, MMP9, MMP2, BAX, and BCL2 was detected by western blotting after EPS8L2 overexpression in HCT116 and SW480 cells. <strong>H</strong>â€“<strong>J</strong> EPS8L2 overexpression and vector HCT116 cells were injected into BALB/c nude mice for 14 days (<em>n</em>â€‰=â€‰4 per group). Statistical results of tumor volumes (<strong>H</strong>), images of subcutaneous xenograft tumors (<strong>I</strong>), and statistical results of tumor weights (<strong>J</strong>) were shown. <strong>K</strong> Expression of EPS8L2 was detected by RT-qPCR in vector and oeEPS8L2 group of subcutaneous xenograft tumors. <strong>L</strong> Expression of EPS8L2, MMP9, MMP2 was detected by western blotting in vector and oeEPS8L2 group of subcutaneous xenograft tumors. <strong>M</strong> Expression of EPS8L2 and Ki67 in subcutaneous xenograft tumors were detected by IHC staining. Scale bars, 100â€‰Î¼m. <strong>N</strong>, <strong>O</strong> EPS8L2 overexpression and vector HCT116 cells were injected into tail vein of BALB/c nude mice for 28 days (<em>n</em>â€‰=â€‰4 per group). Representative images of liver metastasis nodules and HE staining (<strong>N</strong>) and quantification of the liver metastatic nodules were shown (<strong>O</strong>). Scale bars, 500â€‰Î¼m. <strong>P</strong> Representative images of patient-derived organoids (PDOs) images at day 3 are shown in left panel, and quantitative analysis of relative formation rate is shown in right panel. Scale bars, 100â€‰Î¼m. Data are presented as meansâ€‰Â±â€‰SD. ***<em>p</em>â€‰&lt;â€‰0.001, **<em>p</em>â€‰&lt;â€‰0.01, *<em>p</em>â€‰&lt;â€‰0.05.</p></figcaption></figure></section><section id="Sec5"><h3 class="pmc_sec_title">EPS8L2 activates the MAPK signaling pathway</h3>
<p id="Par9">To determine the underlying mechanism, RNA sequencing was performed using EPS8L2 knockdown HCT116 cells. 1430 DEGs were identified in shEPS8L2 cells compared to shNC groups, including 534 upregulated genes and 896 downregulated genes (Fig. <a href="#Fig4" class="usa-link">4A</a>). Notably, several reported oncogenes were downregulated after EPS8L2 silencing, such as FOXQ1, G3BP2, ADAM8, CLDN1, and PPP1R1B [<a href="#CR29" class="usa-link" aria-describedby="CR29">29</a>â€“<a href="#CR33" class="usa-link" aria-describedby="CR33">33</a>]. GO and KEGG analyses revealed that these DEGs were predominantly enriched in the MAPK signaling pathway (Fig. <a href="#Fig4" class="usa-link">4B, C</a>). Correlation analysis using TCGA database also revealed significant positive correlation between EPS8L2 level and activation of the MAPK or ERK signaling pathway (Fig. <a href="#Fig4" class="usa-link">4D, E</a>), suggesting that EPS8L2 may be involved in the activation of the MAPK signaling. To confirm it, we performed western blotting and IHC assays, and found that EPS8L2 knockdown inhibited the phosphorylation of ERK and MEK in CRC cell lines and tissues, and vice versa (Fig. <a href="#Fig4" class="usa-link">4Fâ€“I</a>). Collectively, EPS8L2 activates the MAPK signaling pathway.</p>
<figure class="fig xbox font-sm" id="Fig4"><h4 class="obj_head">Fig. 4. EPS8L2 activates MAPK signaling pathway.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12335500_41419_2025_7929_Fig4_HTML.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5684/12335500/cd25c76c9fd1/41419_2025_7929_Fig4_HTML.jpg" loading="lazy" id="d33e828" height="586" width="790" alt="Fig. 4"></a></p>
<div class="p text-right font-secondary"><a href="figure/Fig4/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p><strong>A</strong> DEGs between shEPS8L2 and shNC HCT116 cells were shown by volcano plot. DEGs are defined by <em>p</em> valueâ€‰&lt;â€‰0.05 and Log<sub>2</sub>|Fold Change|â€‰â‰¥â€‰0.56. <strong>B</strong>, <strong>C</strong> GO (<strong>B</strong>) and KEGG (<strong>C</strong>) enrichment analysis of DEGs in (<strong>A</strong>). <strong>D</strong>, <strong>E</strong> Correlation analysis between EPS8L2 expression and MAPK signaling pathway (<strong>D</strong>) or ERK signaling pathway (<strong>E</strong>) according to TCGA database. <strong>F</strong> Expression of EPS8L2, p-MEK, MEK, p-ERK, and ERK was detected by western blotting in EPS8L2 knockdown and overexpression CRC cells. <strong>G</strong> Expression of EPS8L2, p-MEK, MEK, p-ERK, and ERK was detected by western blotting in vector and oeEPS8L2 groups of subcutaneous xenograft tumors. <strong>H</strong>, <strong>I</strong> Expression of EPS8L2 and p-ERK was detected by IHC staining in EPS8L2 knockdown (<strong>H</strong>) and overexpression (<strong>I</strong>) subcutaneous xenograft tumors. Scale bars, 100â€‰Î¼m.</p></figcaption></figure></section><section id="Sec6"><h3 class="pmc_sec_title">EPS8L2 facilitates YBX1 nuclear accumulation by enhancing its phosphorylation</h3>
<p id="Par10">To further elucidate how EPS8L2 activates MAPK signaling pathway, we performed immunoprecipitation-mass spectrometry (IP-MS) assay to screen potential EPS8L2-interacting proteins. The silver staining results showed a distinct differential band between 40â€‰kDa and 55â€‰kDa in the Flag antibody groups compared to the IgG control groups (Fig. <a href="#Fig5" class="usa-link">5A</a>). This differential band was then subjected to mass spectrometry analysis, which identified 89 interacting proteins in HCT116 cells and 23 interacting proteins in SW480 cells (Fig. <a href="#Fig5" class="usa-link">5B</a>). YBX1 scored high and was selected for validation (Fig. <a href="#Fig5" class="usa-link">5B</a> and Supplementary Fig. <a href="#MOESM1" class="usa-link">3A, B</a>). The interaction between EPS8L2 and YBX1 was confirmed by co-immunoprecipitation (co-IP) and immunofluorescence (IF) assays (Fig. <a href="#Fig5" class="usa-link">5Câ€“E</a>). In addition, we examined effect of YBX1 on MAPK signaling pathway. The results showed that YBX1 knockdown significantly reduced the levels of p-MEK and p-ERK in both HCT116 and HT29 cells, and vice versa (Fig. <a href="#Fig5" class="usa-link">5F</a>). Interestingly, it was observed that YBX1 was also highly expressed in CRC (Supplementary Fig. <a href="#MOESM1" class="usa-link">3C</a>).</p>
<figure class="fig xbox font-sm" id="Fig5"><h4 class="obj_head">Fig. 5. EPS8L2 facilitates YBX1 translocation into nucleus by enhancing its phosphorylation.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12335500_41419_2025_7929_Fig5_HTML.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5684/12335500/aa35f8b66021/41419_2025_7929_Fig5_HTML.jpg" loading="lazy" id="d33e896" height="999" width="772" alt="Fig. 5"></a></p>
<div class="p text-right font-secondary"><a href="figure/Fig5/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p><strong>A</strong> The extracted protein was precipitated with anti-Flag antibody and separated by SDS-PAGE followed by silver staining in HCT116 and SW480 cells. <strong>B</strong> Common proteins identified by mass spectrometry in HCT116 and SW480 cells that interact with EPS8L2 were shown by venn diagram. The top five interacting proteins are listed below. <strong>C</strong> The interaction between exogenous EPS8L2 and exogenous YBX1 was assessed in HEK293T cells. <strong>D</strong> The interaction between endogenous EPS8L2 and endogenous YBX1 was assessed in HCT116 cells. <strong>E</strong> Immunofluorescence staining of EPS8L2 and YBX1 in HCT116 and SW480 cells. Scale bar, 10â€‰Î¼m. <strong>F</strong> Expression of YBX1, p-MEK, MEK, p-ERK, and ERK in YBX1 knockdown and overexpression CRC cells was detected by western blotting. <strong>G</strong> Expression of p-YBX1 and total YBX1 was determined by western blotting in EPS8L2 knockdown and overexpression CRC cells. <strong>H</strong> Co-IP assays were performed to examine the interaction between YBX1 and p-S6K1. <strong>I</strong> Expression of YBX1 after nucleoplasm separation was detected by western blotting in EPS8L2 knockdown and overexpression CRC cells. <strong>J</strong> Immunofluorescence to detected the change of nuclear YBX1 in SW480 cells with EPS8L2 changes. Representative images were shown in left panel and statistical results were shown in right panel. Scale bars, 10â€‰Î¼m. Data are presented as meansâ€‰Â±â€‰SD. ***<em>p</em>â€‰&lt;â€‰0.001.</p></figcaption></figure><p id="Par11">YBX1 is primarily localized in the cytoplasm [<a href="#CR34" class="usa-link" aria-describedby="CR34">34</a>, <a href="#CR35" class="usa-link" aria-describedby="CR35">35</a>]. However, in response to cellular stress, such as ultraviolet (UV) radiation, heat shock, or oxidative stress, YBX1 undergoes phosphorylation by kinases, including AKT and p90 ribosomal S6 kinase, which triggers its rapid translocation into the nucleus [<a href="#CR36" class="usa-link" aria-describedby="CR36">36</a>, <a href="#CR37" class="usa-link" aria-describedby="CR37">37</a>]. Then YBX1 binds to the promoter regions of specific genes, such as p53, BCL2, and PD-L1, and facilitates their transcription [<a href="#CR38" class="usa-link" aria-describedby="CR38">38</a>, <a href="#CR39" class="usa-link" aria-describedby="CR39">39</a>]. Interestingly, we noticed that knockdown of EPS8L2 inhibited YBX1 phosphorylation (active state) without affecting its total expression, and vice versa (Fig. <a href="#Fig5" class="usa-link">5G</a>). As EPS8L2 is not a kinase, it is imperative to explore the underlying mechanism by which EPS8L2 regulates the phosphorylation status of YBX1. Previous research has demonstrated that the phosphorylation of YBX1 can be mediated by multiple kinases, such as S6K1 [<a href="#CR40" class="usa-link" aria-describedby="CR40">40</a>, <a href="#CR41" class="usa-link" aria-describedby="CR41">41</a>]. Really, immunoprecipitation assay revealed that knockdown of EPS8L2 significantly decreased the interaction between p-S6K1 and YBX1 (Fig. <a href="#Fig5" class="usa-link">5H</a>), suggesting that EPS8L2 facilitated the phosphorylation of YBX1 through S6K1. Moreover, we observed a decrease in nuclear YBX1 following EPS8L2 downregulation and an increase in nuclear YBX1 after EPS8L2 upregulation (Fig. <a href="#Fig5" class="usa-link">5I, J</a>).</p></section><section id="Sec7"><h3 class="pmc_sec_title">YBX1 initiates G3BP2 transcription to activate MAPK signaling pathway</h3>
<p id="Par12">To further explain how EPS8L2-YBX1 axis activates MAPK signaling pathway, we utilized CUT&amp;Tag technology to identify the direct target of YBX1 (Fig. <a href="#Fig6" class="usa-link">6A</a>). The CUT&amp;Tag results indicated that YBX1 binding sites were predominantly distributed in promoter regions, with 34.46% of binding sites located within 1â€‰kb of the transcription start site (TSS) (Fig. <a href="#Fig6" class="usa-link">6B</a>). Additionally, YBX1 exhibited higher binding peaks near both the TSS and TES in shNC group, whereas these peaks were significantly diminished in shEPS8L2 group (Fig. <a href="#Fig6" class="usa-link">6C</a>). Next, we analyzed the data from the RNA-seq and CUT&amp;Tag experiments jointly and took the intersection to identify the potential targets of YBX1 (Fig. <a href="#Fig6" class="usa-link">6D</a>). 15 common genes were identified and their expression levels in CRC were analyzed using the GEPIA online tool (Fig. <a href="#Fig6" class="usa-link">6D</a> and Supplementary Fig. <a href="#MOESM1" class="usa-link">4Aâ€“O</a>). Among them, only 7 genes were upregulated in CRC (Supplementary Fig. <a href="#MOESM1" class="usa-link">4Aâ€“G</a>). Therefore, these 7 genes were selected for further investigation by RT-qPCR. The results indicated that the RNA levels of G3BP2 in HCT116 and HT29 cells were significantly reduced following the knockdown of either EPS8L2 or YBX1 (Fig. <a href="#Fig6" class="usa-link">6Eâ€“H</a>). Consistently, the protein levels of G3BP2 were also regulated by EPS8L2 and YBX1 in a similar manner (Fig. <a href="#Fig6" class="usa-link">6I, J</a>).</p>
<figure class="fig xbox font-sm" id="Fig6"><h4 class="obj_head">Fig. 6. YBX1 initiates G3BP2 transcription to activate MAPK signaling pathway.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12335500_41419_2025_7929_Fig6_HTML.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5684/12335500/06d64d3fa496/41419_2025_7929_Fig6_HTML.jpg" loading="lazy" id="d33e1044" height="1000" width="789" alt="Fig. 6"></a></p>
<div class="p text-right font-secondary"><a href="figure/Fig6/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p><strong>A</strong> Schematic representation of CUT&amp;Tag experimental design. <strong>B</strong> Distribution of YBX1 binding sites across the genome, obtained from the comparison between the shNC and shEPS8L2 groups, was shown in pie chart. <strong>C</strong> YBX1 binding intensity around transcription start sites (TSS) and transcription end sites (TES) was displayed by heatmaps and line plots. The red vertical bars typically represent binding strength. <strong>D</strong> The overlap between DEGs identified by RNA-seq and genes with altered YBX1 binding sites identified by CUT&amp;Tag analysis was shown in venn diagram. <strong>E</strong>, <strong>F</strong> Expression of common DEGs was detected by RT-qPCR after EPS8L2 knockdown (<strong>E</strong>) and YBX1 knockdown (<strong>F</strong>) in HCT116 cells. <strong>G</strong>, <strong>H</strong> Expression of G3BP2 was detected by RT-qPCR after EPS8L2 knockdown (<strong>G</strong>) and YBX1 knockdown (<strong>H</strong>) in HT29 cells. <strong>I</strong>, <strong>J</strong> Expression of G3BP2 was detected by western blotting after knockdown or overexpression of EPS8L2 (<strong>I</strong>) and YBX1 (<strong>J</strong>) in CRC cells. <strong>K</strong> YBX1 binding at the G3BP2 promoter region in HCT116 cells was shown by Integrative Genomics Viewer (IGV) images. <strong>L</strong> ChIP-qPCR confirmed the binding of YBX1 to the promoters of G3BP2. <strong>M</strong>â€“<strong>O</strong> G3BP2 promoter activity was detected by dual-luciferase reporter assay in the indicated HEK293T cells. <strong>P</strong> Expression of G3BP2, p-MEK, MEK, p-ERK, and ERK in G3BP2 knockdown and overexpression CRC cells was detected by western blotting. Data are presented as meansâ€‰Â±â€‰SD. **<em>p</em>â€‰&lt;â€‰0.01, ***<em>p</em>â€‰&lt;â€‰0.001, ns no significance.</p></figcaption></figure><p id="Par13">To determine whether EPS8L2-YBX1 axis directly regulates G3BP2 transcription, we analyzed the enrichment of YBX1 on G3BP2 promoter according to the CUT&amp;Tag result and found that YBX1 enriched across the proximal promoter region (0â€‰bp ~ âˆ’850â€‰bp upstream of TSS) of G3BP2 while EPS8L2 knockdown significantly attenuated it (Fig. <a href="#Fig6" class="usa-link">6K</a>), indicating an EPS8L2-dependent chromatin recruitment of YBX1. To further confirm it, we performed chromatin immunoprecipitation (ChIP) assay and found that YBX1 enriched on the region of âˆ’400â€‰bp ~ âˆ’600â€‰bp from TSS (Fig. <a href="#Fig6" class="usa-link">6L</a> and Supplementary Fig. <a href="#MOESM1" class="usa-link">4P</a>). Subsequently, we performed dual-luciferase reporter assays. Consistently, YBX1 overexpression enhanced G3BP2 transcription activity (Fig. <a href="#Fig6" class="usa-link">6M</a>). Besides, EPS8L2 knockdown inhibited the activity of G3BP2 luciferase reporter while YBX1 overexpression reversed it, and vice versa (Fig. <a href="#Fig6" class="usa-link">6N, O</a>).</p>
<p id="Par14">As G3BP2 is a member of the RAS-GTPase-activating protein (G3BP) family [<a href="#CR42" class="usa-link" aria-describedby="CR42">42</a>] and G3BP2 is reported to activate the MAPK signaling pathway [<a href="#CR43" class="usa-link" aria-describedby="CR43">43</a>], we hypothesized that G3BP2 may influence the activity of MAPK signaling pathway in CRC. Western blotting showed that the phosphorylation of MEK and ERK was significantly reduced after G3BP2 knockdown and vice versa (Fig. <a href="#Fig6" class="usa-link">6P</a>). In conclusion, EPS8L2 promotes YBX1-dependent transcription of G3BP2, leading to MAPK signaling activation.</p></section><section id="Sec8"><h3 class="pmc_sec_title">EPS8L2 promotes the development of CRC in a G3BP2-dependent manner</h3>
<p id="Par15">To explore whether the ability of EPS8L2 to promote CRC cell proliferation is dependent on G3BP2, we conducted both in vitro and in vivo rescue experiments. The results showed that EPS8L2 overexpression significantly promoted the proliferation and migration abilities of HCT116 and SW480 cells while G3BP2 knockdown reversed it, and vice versa (Fig. <a href="#Fig7" class="usa-link">7Aâ€“H</a>). Additionally, the activation of MAPK signaling pathway induced by EPS8L2 overexpression could be reversed by G3BP2 knockdown, whereas inhibition of MAPK signaling pathway caused by EPS8L2 knockdown could be restored by G3BP2 overexpression (Fig. <a href="#Fig7" class="usa-link">7I, J</a>). In vivo experiments showed that G3BP2 knockdown could impede increased tumor growth and tumor weight caused by EPS8L2 overexpression (Fig. <a href="#Fig7" class="usa-link">7Kâ€“M</a>). IHC staining results showed that G3BP2 knockdown reversed EPS8L2 overexpression-induced Ki67 upregulation (Fig. <a href="#Fig7" class="usa-link">7N</a>). Conclusively, EPS8L2 promotes CRC tumorigenesis and metastasis via G3BP2.</p>
<figure class="fig xbox font-sm" id="Fig7"><h4 class="obj_head">Fig. 7. EPS8L2 promotes the progression of CRC in a G3BP2-dependent manner.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12335500_41419_2025_7929_Fig7_HTML.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5684/12335500/6277ee91cdc8/41419_2025_7929_Fig7_HTML.jpg" loading="lazy" id="d33e1159" height="1000" width="728" alt="Fig. 7"></a></p>
<div class="p text-right font-secondary"><a href="figure/Fig7/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p><strong>A</strong>â€“<strong>D</strong> Cell proliferation was detected by CCK-8 assay (<strong>A, B</strong>) and colony formation assay (<strong>C, D</strong>) in the indicated CRC cells. <strong>E-H</strong> Transwell migration (<strong>E</strong>, <strong>F</strong>) and wound healing assay (<strong>G, H</strong>) were performed to assess the cell migration ability of indicated CRC cells. Scale bars, 100â€‰Î¼m. <strong>I</strong>, <strong>J</strong> Expression of EPS8L2, G3BP2, p-MEK, MEK, p-ERK, and ERK was detected by western blotting in the indicated CRC cells. <strong>K</strong>â€“<strong>M</strong> Indicated HCT116 cells were injected into BALB/c nude mice for 14 days (<em>n</em>â€‰=â€‰5 per group). Images of subcutaneous xenograft tumors (<strong>K</strong>), statistical results of tumor volumes (<strong>L</strong>), and statistical results of tumor weights (<strong>M</strong>) were shown. <strong>N</strong> Expression of EPS8L2, G3BP2, and Ki67 were detected by IHC staining in indicated subcutaneous xenograft tumors. Scale bars, 100â€‰Î¼m. Data are presented as meansâ€‰Â±â€‰SD. ***<em>p</em>â€‰&lt;â€‰0.001, **<em>p</em>â€‰&lt;â€‰0.01, *<em>p</em>â€‰&lt;â€‰0.05.</p></figcaption></figure></section><section id="Sec9"><h3 class="pmc_sec_title">
<em>Eps8l2</em> knockout inhibits tumorigenesis in the AOM/DSS model</h3>
<p id="Par16">To further investigate whether Eps8l2 is involved in tumorigenesis, we generated <em>Eps8l2</em> knockout mice (<em>Eps8l2</em><sup>âˆ’/âˆ’</sup>) and wild-type littermates (<em>Eps8l2</em><sup>+/+</sup>) to induce colorectal cancer (Fig. <a href="#Fig8" class="usa-link">8A</a>). We confirmed the deletion of Eps8l2 in the colorectal tissues of <em>Eps8l2</em> knockout mice (Fig. <a href="#Fig8" class="usa-link">8B</a>). We observed that the length of colons from <em>Eps8l2</em><sup>-/-</sup> mice was longer than that in <em>Eps8l2</em><sup>+/+</sup> mice after induction (Fig. <a href="#Fig8" class="usa-link">8C, D</a>), suggesting an alleviated inflammation after <em>Eps8l2</em> deletion. In addition, the number of colorectal tumors in <em>Eps8l2</em><sup>âˆ’/âˆ’</sup> mice was significantly reduced compared with that in <em>Eps8l2</em><sup>+/+</sup> mice (Fig. <a href="#Fig8" class="usa-link">8E, F</a>). Moreover, tumor size was also decreased after <em>Eps8l2</em> knockout (Fig. <a href="#Fig8" class="usa-link">8G</a>). Consistently, H&amp;E staining revealed low-grade dysplasia in the colon tissues from Eps8l2<sup>-/-</sup> mice (Fig. <a href="#Fig8" class="usa-link">8H</a>). To determine whether the Eps8l2-G3bp2 axis contributes to tumor development in this AOM/DSS model, we examined G3bp2 and Ki67 expression by IHC staining and found a significant decrease of G3bp2 and Ki67 expression levels in tumor tissues from <em>Eps8l2</em><sup>âˆ’/âˆ’</sup> mice (Fig. <a href="#Fig8" class="usa-link">8I</a>). The levels of p-Mek and p-Erk were significantly reduced in <em>Eps8l2</em><sup>âˆ’/âˆ’</sup> tumors (Fig. <a href="#Fig8" class="usa-link">8J</a>). Taken together, these data indicate that EPS8L2 is a pivot oncogene involved in CRC progression.</p>
<figure class="fig xbox font-sm" id="Fig8"><h4 class="obj_head">Fig. 8. <em>Eps8l2</em> knockout inhibits tumorigenesis in the AOM/DSS model.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12335500_41419_2025_7929_Fig8_HTML.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5684/12335500/d5ec557acf1b/41419_2025_7929_Fig8_HTML.jpg" loading="lazy" id="d33e1354" height="565" width="790" alt="Fig. 8"></a></p>
<div class="p text-right font-secondary"><a href="figure/Fig8/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p><strong>A</strong> Schematic timeline of AOM/DSS experimental design. <strong>B</strong> Expression of Eps8l2 in colorectal tissues was detected by western blotting. <strong>C</strong> Representative images of colons of <em>Eps8l2</em><sup>+/+</sup> and <em>Eps8l2</em><sup>âˆ’/âˆ’</sup> mice after AOM/DSS treatment (<em>n</em>â€‰=â€‰9 per group). <strong>D</strong> Colon lengths of <em>Eps8l2</em><sup>+/+</sup> and <em>Eps8l2</em><sup>âˆ’/âˆ’</sup> mice after AOM/DSS treatment were measured. <strong>E</strong> Representative images of colorectal tumors from <em>Eps8l2</em><sup>+/+</sup> and <em>Eps8l2</em><sup>âˆ’/âˆ’</sup> mice after AOM/DSS treatment. Arrows indicate tumors. <strong>F</strong> The number of tumors in <em>Eps8l2</em><sup>+/+</sup> and <em>Eps8l2</em><sup>âˆ’/âˆ’</sup> mice was shown. <strong>G</strong> The number of different size tumors in <em>Eps8l2</em><sup>+/+</sup> and <em>Eps8l2</em><sup>âˆ’/âˆ’</sup> mice. <strong>H</strong> Representative H&amp;E staining of colon tissues obtained from <em>Eps8l2</em><sup>+/+</sup> and <em>Eps8l2</em><sup>âˆ’/âˆ’</sup> mice. Scale bars, 2â€‰mm. <strong>I</strong> Expression of Eps8l2, G3bp2, and Ki67 in tumor tissues was detected by IHC staining. Scale bars, 100â€‰Î¼m. <strong>J</strong> Expression of Eps8l2, G3bp2, p-Mek, Mek, p-Erk, and Erk were detected by western blotting in tumor tissues obtained from <em>Eps8l2</em><sup>+/+</sup> and <em>Eps8l2</em><sup>âˆ’/âˆ’</sup> mice. <strong>K</strong> Schematic model for the findings of this work: EPS8L2 can promote the proliferation and migration of CRC. More importantly, EPS8L2 can enhance the interaction between YBX1 and its kinase p-S6K1, leading to the increase of YBX1 phosphorylation and nuclear translocation, promoting the transcription of downstream G3BP2 and activating the MAPK signaling pathway. Data are presented as meansâ€‰Â±â€‰SD. ***<em>p</em>â€‰&lt;â€‰0.001, **<em>p</em>â€‰&lt;â€‰0.01, ns no significance.</p></figcaption></figure></section></section><section id="Sec10"><h2 class="pmc_sec_title">Discussion</h2>
<p id="Par17">Colorectal cancer persists as a leading cause of global cancer mortality, with American Cancer Society (ACS) data in 2024 reporting approximately 153,000 new cases and 53,000 deaths annually in the US alone [<a href="#CR1" class="usa-link" aria-describedby="CR1">1</a>]. The pathogenesis of CRC is characterized by a complex interplay of multistep genetic and epigenetic alterations, coupled with dysregulation of the tumor microenvironment, which collectively drive malignant progression [<a href="#CR44" class="usa-link" aria-describedby="CR44">44</a>, <a href="#CR45" class="usa-link" aria-describedby="CR45">45</a>]. In this study, we identified EPS8L2 as a significantly upregulated gene in CRC tumor tissues, where it exhibits oncogenic properties. Clinical correlation analysis revealed that elevated EPS8L2 expression is associated with advanced tumor grade, lymph node metastasis, and unfavorable patient prognosis, suggesting its potential role in CRC progression and aggressiveness. Functional characterization of EPS8L2 revealed its critical role in promoting CRC progression. Furthermore, utilizing patient-derived colorectal cancer organoids as a clinically relevant model system, we demonstrated that EPS8L2 overexpression markedly enhanced organoid formation efficiency, reinforcing its functional role in promoting tumorigenic capacity. Both in vitro and in vivo experiments demonstrated that EPS8L2 overexpression significantly enhanced proliferative and metastatic capacities of CRC cells. Conversely, knockout of Eps8l2 markedly attenuated tumor development in an AOM/DSS-induced CRC mouse model. Collectively, our findings position EPS8L2 as both a potential diagnostic biomarker and a novel therapeutic target for colorectal cancer intervention. Interestingly, we observed that EPS8L2 exerts more significant oncogenic effects in vivo, which could be attributed to the following factor. The tumor microenvironment (TME) in vivo provides complex cell-cell interactions, extracellular matrix components, and immune modulation that are absent in vitro. EPS8L2 may enhance tumor growth by influencing stromal crosstalk and angiogenesis, or reshaping the immune microenvironment in vivo. Secondly, the longer duration and systemic action of EPS8L2 in vivo resulted in a more significant cumulative effect of its tumorigenic activity compared to short-term in vitro experiments. Therefore, it will be worthwhile to explore the relationship of EPS8L2 with the tumor microenvironment and tumor immunity.</p>
<p id="Par18">MAPK signaling cascade serves as a central regulator of essential cellular processes, governing proliferation, differentiation, cell survival, and programmed cell death. This highly conserved signaling pathway operates through sequential phosphorylation events mediated by a three-tiered kinase module: MAPKKK, MEK, and MAPK [<a href="#CR46" class="usa-link" aria-describedby="CR46">46</a>]. Pathological dysregulation of the MAPK cascade constitutes a fundamental driver of oncogenesis, with particular relevance to colorectal carcinogenesis. In CRC, constitutive activation of the MAPK/ERK signaling axis has been mechanistically linked to multiple malignant phenotypes, including sustained tumor proliferation, metastatic dissemination, and the development of therapeutic resistance [<a href="#CR47" class="usa-link" aria-describedby="CR47">47</a>, <a href="#CR48" class="usa-link" aria-describedby="CR48">48</a>]. Integrative analysis of transcriptomic sequencing data and correlation studies revealed a significant association between EPS8L2 and MAPK signaling pathway activation in CRC. Functional characterization demonstrated that EPS8L2 serves as a potent activator of MAPK signaling, mechanistically contributing to CRC progression and metastatic dissemination through this oncogenic pathway.</p>
<p id="Par19">YBX1, a multifunctional transcription factor, regulates critical processes including cell proliferation, differentiation, and apoptosis [<a href="#CR38" class="usa-link" aria-describedby="CR38">38</a>, <a href="#CR49" class="usa-link" aria-describedby="CR49">49</a>]. Emerging evidence has established YBX1 as a multifunctional oncoprotein contributing to tumorigenesis across multiple cancer types [<a href="#CR50" class="usa-link" aria-describedby="CR50">50</a>â€“<a href="#CR52" class="usa-link" aria-describedby="CR52">52</a>]. Notably, S6K1-mediated phosphorylation facilitates YBX1 nuclear translocation, thereby activating PD-L1 transcriptional upregulation in HCC [<a href="#CR40" class="usa-link" aria-describedby="CR40">40</a>]. So, we identified YBX1 as a novel interaction partner of EPS8L2 that mediates MAPK pathway activation. Second, we demonstrated that EPS8L2 facilitates the formation of a molecular complex between YBX1 and its activating kinase p-S6K1, thereby promoting YBX1 phosphorylation and subsequent nuclear translocation. However, there is a limitation about above conclusion. We did not perform fluorescence recovery after photobleaching (FRAP) experiments to dynamically monitor YBX1 nuclear accumulation in response to EPS8L2 modulation. Thus, the observed accumulation of YBX1 may also be caused by other factors rather than nuclear translocation, which needs to be defined in the future.</p>
<p id="Par20">G3BP2, a conserved RNA-binding protein within the RAS-GAP SH3 domain-binding protein (G3BPs) family [<a href="#CR42" class="usa-link" aria-describedby="CR42">42</a>], plays established roles in tumorigenesis and inflammatory diseases [<a href="#CR30" class="usa-link" aria-describedby="CR30">30</a>, <a href="#CR42" class="usa-link" aria-describedby="CR42">42</a>]. Our CUT&amp;Tag analysis revealed that G3BP2 is co-regulated downstream of EPS8L2 and YBX1. Previous study reported that G3BP2 may function as an oncogene in CRC [<a href="#CR53" class="usa-link" aria-describedby="CR53">53</a>]. Another study indicated that G3BP2 could enhance radioresistance of colorectal cancer cells [<a href="#CR54" class="usa-link" aria-describedby="CR54">54</a>]. Our functional studies demonstrated that G3BP2 knockdown significantly attenuated EPS8L2-driven proliferative and metastatic phenotypes. Moreover, knockdown of G3BP2 effectively suppressed EPS8L2-mediated tumor growth in vivo, suggesting that G3BP2 is a critical downstream effector of EPS8L2 in cancer progression. Notably, these findings align with prior reports that G3BP2 depletion impairs MAPK signaling activation in MCF7 cells, implying a conserved mechanistic role of G3BP2 in oncogenic pathway regulation [<a href="#CR43" class="usa-link" aria-describedby="CR43">43</a>]. Our mechanistic investigations revealed that knockdown of G3BP2 effectively abolished MAPK pathway activation induced by EPS8L2 overexpression, and vice versa. These findings establish G3BP2 as an essential molecular effector in EPS8L2-driven oncogenic transformation.</p>
<p id="Par21">In conclusion, our study establishes EPS8L2 as a critical oncogenic driver in colorectal cancer progression and metastasis. Mechanistically, we demonstrate that EPS8L2 physically interacts with YBX1 and promotes its nuclear accumulation through phosphorylation-dependent regulation, consequently enhancing G3BP2 transcription and activating the MAPK signaling pathway. Importantly, genetic ablation of Eps8l2 significantly attenuated tumor development in the AOM/DSS-induced CRC model. These findings collectively identify the EPS8L2-YBX1-G3BP2 signaling axis as a novel and potentially targetable pathway for CRC therapeutic intervention.</p></section><section id="Sec11"><h2 class="pmc_sec_title">Methods</h2>
<section id="Sec12"><h3 class="pmc_sec_title">DEGs, GO, and KEGG analysis</h3>
<p id="Par22">Two GEO datasets (<a href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE75970" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">GSE75970</a> and <a href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE103512" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">GSE103512</a>) were downloaded from the Gene Expression Omnibus (GEO: <a href="https://www.ncbi.nlm.nih.gov/geo" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://www.ncbi.nlm.nih.gov/geo</a>). The TCGA+GTEx dataset was obtained from the TCGA and GTEx databases. DEGs analysis was performed using limma v3.56.2 package in R. The selection criteria for DEGs were |log<sub>2</sub>FC|â€‰â‰¥â€‰0.58 and <em>p</em>â€‰&lt;â€‰0.05. The RTK-related genes list was downloaded from Genecards websites. DEGs in three datasets were visualized by volcano plots, and overlap of DEGs across these datasets was shown by venn diagram. 665 common DEGs were subjected to GO and KEGG enrichment analyses using the clusterProfiler package in R. The <em>p</em> values were calculated based on the hypergeometric distribution.</p></section><section id="Sec13"><h3 class="pmc_sec_title">Survival analysis</h3>
<p id="Par23">For survival analysis, according to TCGA database, TPM data and clinical survival data were downloaded from TCGA COAD-READ cohort. Samples were divided into high and low expression groups according to the median value of EPS8L2. Overall survival curves were generated using ggsurvplot function from survminer R package. <em>P</em> values were calculated by log-rank test.</p>
<p id="Par24">For survival analysis, according to CRC tissue array, samples were divided into high and low expression groups according to the IHC score. IHC score above 3 indicated high EPS8L2 expression, while IHC score below 3 indicated low EPS8L2 expression. Survival analysis in different EPS8L2 expression groups was generated using Kaplanâ€“Meier and <em>p</em> values were calculated by log-rank test.</p></section><section id="Sec14"><h3 class="pmc_sec_title">Human specimen</h3>
<p id="Par25">Clinical human colorectal cancer tissues were collected from the First Affiliated Hospital of Zhengzhou University. CRC specimens were collected from the First Affiliated Hospital of Zhengzhou University following informed consent procedures. This study was reviewed and approved by the Institutional Review Board and the Ethics Committee of Zhengzhou University. Additionally, human CRC tissue microarray was purchased from Shanghai Outdo Biotech Company (Shanghai, China).</p></section><section id="Sec15"><h3 class="pmc_sec_title">Cell culture</h3>
<p id="Par26">Human colorectal cancer cells HCT116, HT29, SW480, and RKO were obtained from the American Type Culture Collection. Human cell line HEK293T (Cat# GNHu17) was purchased from the Cell Bank of the Chinese Academy of Sciences. All cells were cultured in cell incubator (Thermo Fisher Scientific) with 37â€‰Â°C and 5% CO<sub>2</sub>. All cells were grown in DMEM medium (Viva, #C3113-0500). All media were supplemented with 10% fetal bovine serum (FBS, Lonsera, #S711-001S) and 1% Penicillin-Streptomycin antibiotics solution (Beyotime, #C0222). All cell lines were validated by STR profiling and confirmed to be free from mycoplasma contamination.</p></section><section id="Sec16"><h3 class="pmc_sec_title">Knockdown and overexpression plasmid construction</h3>
<p id="Par27">To generate stable knockdown CRC cell lines targeting EPS8L2, YBX1, and G3BP2, we employed the pLKO.1-puro lentiviral vector. Gene-specific shRNA sequences were designed using the Sigma-Aldrich online tool (<a href="https://www.sigmaaldrich.cn/CN/zh/semiconfigurators/shrna?activeLink=productSearch" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://www.sigmaaldrich.cn/CN/zh/semiconfigurators/shrna?activeLink=productSearch</a>) and subsequently cloned into the pLKO.1-puro backbone.</p>
<p id="Par28">For overexpression plasmid construction, coding sequences of human EPS8L2 and G3BP2 were cloned into lentiviral vector pCDH-CMV-MCS-EF1-RFP-T2A-Puro (Tsingke, China) to generate EPS8L2 or G3BP2 overexpression plasmids. Coding sequences of human YBX1 were cloned into lentiviral vector pCDH-copGFP-puro (Tsingke, China) to generate YBX1 overexpression plasmids. When constructing the EPS8L2 and YBX1 overexpression vector, we added a Flag and His tag to the 3â€™ end of the CDS, respectively. Overexpression primers and shRNA primers were synthesized by Sangon Biotech (Shanghai, China). The primer sequences of EPS8L2, YBX1, and G3BP2 shRNA and CDS were listed in Supplementary Tables <a href="#MOESM1" class="usa-link">1</a> and <a href="#MOESM1" class="usa-link">2</a>, respectively.</p></section><section id="Sec17"><h3 class="pmc_sec_title">Lentiviral infection</h3>
<p id="Par29">The knockdown or overexpression plasmid and control plasmid were transfected into HEK293T cells with lentiviral packaging plasmids psPAX2 (Addgene, #12260) and pMD2.G (Addgene, #12259) according to protocol of jetPRIME reagent (Polyplus, #101000046). Virus medium was filtered through a 0.45-micron filter and subsequently mixed 1:1 with complete medium for culturing target cells. Polybrene (Yeasen, #40804ES86) was added to enhance infection. After 24â€‰h, the medium was replaced with fresh complete medium. The infected cells were subjected to puromycin selection (0.8â€‰Î¼g/mL for HCT116 cells, 2â€‰Î¼g/mL for HT29 cells, 1â€‰Î¼g/mL for SW480 cells, and 1â€‰Î¼g/mL for RKO cells) for 3â€“4 days to establish stable knockdown or overexpression cell lines. RT-qPCR and western blotting were performed to detect EPS8L2 knockdown or overexpression efficiency.</p></section><section id="Sec18"><h3 class="pmc_sec_title">RNA isolation and quantitative real-time PCR (RT-qPCR)</h3>
<p id="Par30">Total RNA from whole cell lysates or tissues was isolated by Total RNA Extraction Reagent (Vazyme, #R711-01). The concentration and purity of total RNA were determined by NanoDrop2000 (Thermo Fisher, USA). The HiScript III RT SuperMix for RT-qPCR (+gDNA wiper) (Vazyme, #R323) was used for reverse transcription reaction. RT-qPCR was peformed on CFX96TM Real-Time System (Bio-RAD, #CT032238) using Hieff<sup>Â®</sup> qPCR SYBR Green Master Mix (No Rox) (Yeasen, 11201ES03). Data analysis was used 2<sup>âˆ’Î”Î”Ct</sup> method and normalized to Î²-actin. The primer sequences were presented in Supplementary Table <a href="#MOESM1" class="usa-link">3</a>.</p></section><section id="Sec19"><h3 class="pmc_sec_title">Western blotting</h3>
<p id="Par31">Samples were lysed using RIPA lysis buffer (Beyotime, #P0013B) containing protease inhibitor PMSF (Solarbio, #P0100), and extracted protein was quantified using BCA assay (Beyotime, #P0012). The proteins were separated using SDS-polyacrylamide gel electrophoresis (PAGE) and transferred to polyvinylidene fluoride (PVDF) membrane (Merck Millipore, #IPVH00010). The membranes were blocked with 5% non-fat milk for 2â€‰h at room temperature, followed by incubation with primary antibody overnight at 4â€‰Â°C. The next day, the membranes were incubated with secondary antibody for 1â€‰h at room temperature. Protein expression was visualized using BeyoECL Star (Beyotime, #P0018AS) by enhanced chemiluminescent system BG-gds AUTO 720 (Baygene Biotech, China). Î²-actin was used as the internal reference protein. The antibodies were listed in Supplementary Table <a href="#MOESM1" class="usa-link">4</a>.</p></section><section id="Sec20"><h3 class="pmc_sec_title">Cell counting kit-8 (CCK-8) assay</h3>
<p id="Par32">Cell viability was assessed by CCK-8 assay (APExBIO, #K1018). Cells of logarithmic growth phase were seeded into 96-well plates at a density of 1â€‰Ã—â€‰10<sup>3</sup> cells in 100â€‰Î¼L medium per well. Ten microliters CCK-8 reagent was added to each well at 0, 24, 48, 72, 96â€‰h and incubated at 37â€‰Â°C for 1â€‰h. The absorbance at 450â€‰nm was measured using microplate reader (Bio-Rad, USA) at corresponding time.</p></section><section id="Sec21"><h3 class="pmc_sec_title">Colony formation assay</h3>
<p id="Par33">CRC cells (500 cells/well for HCT116 cells, 800 cells/well for HT29 cells, 800 cells/well for SW480 cells, and 700 cells/well for RKO cells) were seeded into 6-well plates and cultured at 37â€‰Â°C for 8â€“18 days. Then cells were fixed with 4% paraformaldehyde for 30â€‰min and stained with 0.1% crystal violet for 15â€‰min. Colony numbers were counted and recorded by Image J software.</p></section><section id="Sec22"><h3 class="pmc_sec_title">Transwell migration assay</h3>
<p id="Par34">The migration assay was performed using transwell chambers (BIOFIL, TCS003012). CRC cells (5â€‰Ã—â€‰10<sup>4</sup> cells/well for HCT116 cells, 2â€‰Ã—â€‰10<sup>5</sup> cells/well for HT29 cells, 1â€‰Ã—â€‰10<sup>5</sup> cells/well for SW480 cells, and 2â€‰Ã—â€‰10<sup>5</sup> cells/well for RKO cells) were seeded into the upper chamber with serum-free DMEM, and then 20% FBS DMEM was added to the lower chamber. After 48â€‰h, CRC cells were fixed in 4% paraformaldehyde for 30â€‰min and stained with 0.1% crystal violet for 15â€‰min. Images were captured using the Eclipse Ti2 microscope (Nikon, Japan). Migratory cells were quantified using ImageJ software.</p></section><section id="Sec23"><h3 class="pmc_sec_title">Wound healing assay</h3>
<p id="Par35">CRC cells were seeded in 6-well plates and allowed to grow until reaching confluency. Ten microliters pipette tip (Axygen, #AXYT300) was used to create a scratch in the confluent cell layer. After 48â€‰h, images of cells migrating into scratched area were captured using inverted microscope (Eclipse Ti2, Nikon, Japan). The migration distance was measured, and the migration rate was calculated with the following formula: (Width at 0â€‰h âˆ’ Width at 48â€‰h)/Width at 0â€‰h.</p></section><section id="Sec24"><h3 class="pmc_sec_title">Apoptosis assay</h3>
<p id="Par36">The apoptotic rate of CRC cells was detected using apoptosis detection kit (Yeasen, #40302ES60). Cells were treated with EDTA-free trypsin and then collected by centrifugation at 300â€‰Ã—â€‰g for 5â€‰min at 4â€‰Â°C. After cells were washed twice with pre-cooled PBS, 100â€‰Î¼L 1Ã—Binding Buffer was added to resuspend cells. Then, 10â€‰Î¼L PI staining solution and 5â€‰Î¼L Annexin V-FITC were added, and the mixture was gently mixed. The reaction was carried out in the dark at room temperature for 10â€“15â€‰min. After 400â€‰Î¼L 1Ã—Binding Buffer was added to each tube, mixture was gently mixed and prepared to flow cytometry analysis.</p></section><section id="Sec25"><h3 class="pmc_sec_title">Animal experiments</h3>
<p id="Par37">All animal experiments were performed at the Laboratory Animal Center of the Zhengzhou University and approved by the Ethics Committee of Zhengzhou University (ZZUIRB2023-320, 15 December 2023). Four-week-old female BALB/c nude mice were purchased from SPF Biotechnology Co., Ltd. (Beijing, China) and then housed in barrier system. No statistical methods were applied to choose the number of mice. For this analysis; blinding was not conducted. Mice were randomly divided into appropriate groups based on the experimental design. For EPS8L2 knockdown subcutaneous tumor model, HCT116 cells (6â€‰Ã—â€‰10<sup>6</sup> per mouse) in 100â€‰Î¼L were subcutaneously transplanted into nude mice in both the shNC group and the shEPS8L2 group (<em>n</em>â€‰=â€‰6 per group). For EPS8L2 overexpression subcutaneous tumor model, HCT116 cells (5â€‰Ã—â€‰10<sup>6</sup> per mouse) in 100â€‰Î¼L were subcutaneously injected into nude mice in both the vector group and the oeEPS8L2 group (<em>n</em>â€‰=â€‰4 per group). For rescue subcutaneous tumor model, HCT116 cells (5â€‰Ã—â€‰10<sup>6</sup> per mouse) in 100â€‰Î¼L were subcutaneously injected into nude mice (<em>n</em>â€‰=â€‰5 per group). After the subcutaneous tumors became detectable, tumor size was measured every other day, and the tumor volume was calculated using the formula: volume (mm<sup>3</sup>)â€‰=â€‰lengthâ€‰Ã—â€‰width<sup>2</sup>/2. The tumor tissues were used for western blotting, RT-qPCR, and IHC.</p>
<p id="Par38">For EPS8L2 knockdown tail vein metastasis model, the mice were randomly divided into shNC and shEPS8L2 groups. Each mouse was injected with 5â€‰Ã—â€‰10<sup>6</sup> cells in 100â€‰Î¼L sterile PBS via the tail vein and observed for 33 days (<em>n</em>â€‰=â€‰4 per group). For EPS8L2 overexpression tail vein metastasis model, the mice were randomly divided into vector and oeEPS8L2 groups. Each mouse was injected with 3â€‰Ã—â€‰10<sup>6</sup> cells in 100â€‰Î¼L sterile PBS via the tail vein and observed for 28 days (<em>n</em>â€‰=â€‰4 per group). The mice were sacrificed at the experimental endpoint, and the livers were collected and photographed. The number of liver metastatic nodules was counted. The liver tissues were fixed in 4% paraformaldehyde for 24â€‰h and embedded in paraffin for hematoxylin and eosin (HE) staining.</p>
<p id="Par39">For AOM/DSS model, <em>Eps8l2</em> KO mice were obtained from Cyagen biosciences (KOAI231030WX1, China) and confirmed by genotyping. 7-week-old female mice (<em>n</em>â€‰=â€‰9 per group) were treated with AOM (Sigma, #A5486-25mg) at 10â€‰mg/kg in PBS via intraperitoneal injection on Day 0. Seven days later, 2% DSS was given in drinking water for 7 days, followed by regular water for two weeks. After three cycles of DSS treatment, the mice were sacrificed 84 days after AOM injection. Mice colon length was measured, and visible tumors were counted. Finally, the colons were photographed and collected for subsequent analysis. The genotyping primers are listed in Supplementary Table <a href="#MOESM1" class="usa-link">5</a>.</p></section><section id="Sec26"><h3 class="pmc_sec_title">Immunohistochemistry (IHC) staining and scoring</h3>
<p id="Par40">Human or mouse tissue samples were fixed in 4% paraformaldehyde and embedded in paraffin. Before staining, the sections were deparaffinized in xylene and rehydrated in 100%, 95%, and 80% alcohols. Tissue sections were incubated with 3% hydrogen peroxide solution for 15â€‰min to inhibit endogenous peroxidase activity. Subsequently, they were blocked with 10% Donkey Serum (Solarbio, #SL050) at room temperature for 45â€‰min. Antigen retrieval was performed by heating the slices in antigen retrieval solution at 100â€‰Â°C for 15â€‰min. Next, the sections were incubated overnight at 4â€‰Â°C with primary antibody. The next day, they were incubated with secondary antibody for 1â€‰h at room temperature. Then, 3,3â€²-Diaminutesobenzidine (DAB) Horseradish Peroxidase Color Development Kit (ZSGB-BIO, #ZLI9019) was used as chromogen, and hematoxylin was applied for nuclear counterstain. Finally, the sections were mounted using neutral balsam after dehydration. The slides were imaged using GCell ImageViewer (GCell, China). Well-stained areas were selected to observe the staining intensity and stained area of positive cells under the microscope. The score of intensity was categorized into four levels: negative (0), weak (1), moderate (2), and strong (3). The positive cell percentage was divided into five levels 0% (0), 0â€“25% (1), 26â€“50% (2), 51â€“75% (3), and 76â€“100% (4). The final staining score was the sum of the staining intensity and staining area scores, with a range of 0 to 7. The antibodies were listed in Supplementary Table <a href="#MOESM1" class="usa-link">4</a>.</p></section><section id="Sec27"><h3 class="pmc_sec_title">RNA-sequencing (RNA-seq) and analysis</h3>
<p id="Par41">EPS8L2 knockdown (shEPS8L2-1) and control HCT116 (shNC) cells were used for transcriptome sequencing. Total RNA was extracted using Total RNA Extraction Reagent (Vazyme, #R711-01), and the purity and concentration of RNA were measured using NanoDrop2000 spectrophotometer (Thermo Fisher, USA). The RNA samples were sent to Berry Genomics for RNA sequencing. The Illumina NovaSeq6000 sequencing platform (Illumina, USA) was used for sequencing. DEGs were defined using the following threshold: |log<sub>2</sub>FC|â€‰â‰¥ 0.56 and <em>p</em>â€‰&lt;â€‰0.05. The clusterProfiler R package was used for GO and KEGG enrichment analysis of DEGs.</p></section><section id="Sec28"><h3 class="pmc_sec_title">Immunoprecipitation and mass spectrometry</h3>
<p id="Par42">The cells were collected and lysed using RIPA lysis buffer (Beyotime, #P0013B) containing protease inhibitor PMSF (Solarbio, #P0100). Meanwhile, Protein A/G agarose beads (Engibody, #IF0001) were prewashed with RIPA lysis buffer. For each sample, 30â€‰Î¼L pre-washed beads were added and incubated at 4â€‰Â°C for 1â€‰h to remove non-specific proteins. The samples were centrifuged at 13,000â€‰rpm for 15â€‰min at 4â€‰Â°C, then the supernatant was collected and transferred to a new tube. The cell lysates were then incubated with specific antibodies overnight at 4â€‰Â°C, then the pre-washed beads were added into the mixture for 4â€‰h at 4â€‰Â°C. After 2500â€‰rpm for 5â€‰min at 4â€‰Â°C centrifugation, the supernatant was discarded. 2Ã— SDS loading was added into the beads and boiled for 15â€‰min to get samples. For co-IP/MS, IgG or Flag antibody was added into HCT116 and SW480 cell lysates. Immunocomplexes were subjected to SDS-PAGE separation. Then, the gels were stained with the silver staining kit (Beyotime, #P0017S), and differential bands were cut off for MS analysis. MS analysis was performed by Oebiotech (Shanghai, China).</p></section><section id="Sec29"><h3 class="pmc_sec_title">Nuclear-cytoplasmic separation assay</h3>
<p id="Par43">The nuclear-cytoplasmic separation assay was performed according to Nuclear/Cytosol Fractionation Kit (Phygene, #PH1466) manufacturerâ€™s protocol. Briefly, the CRC cell lines were collected into centrifuge tubes. The pellets were washed twice with pre-cooled PBS, centrifuged at 500â€‰Ã—â€‰<em>g</em> at 4â€‰Â°C for 3â€‰min after each wash. Next, 400 Î¼L pre-cooled extraction buffer A was added to the cell pellet, and the mixture was incubated on ice for 30â€‰min with vertexing every 5â€‰min to ensure thorough mixing. After shaking and mixing, the samples were centrifuged at 12,000â€‰Ã—â€‰<em>g</em> at 4â€‰Â°C for 5â€‰min. The supernatants that contained cytoplasmic proteins were transferred to precooled centrifuge tubes, while the pellets were resuspended in pre-cooled PBS and washed 3 times. The remaining pellet was nuclear fraction. RIPA lysis buffer with protease inhibitor PMSF was added to cytoplasmic fraction and nuclear fraction for 30â€‰min on ice. The concentrations of cytoplasmic and nuclear proteins were measured using the BCA assay and analyzed by western blotting.</p></section><section id="Sec30"><h3 class="pmc_sec_title">CUT&amp;Tag sequencing and analysis</h3>
<p id="Par44">EPS8L2 knockdown (shEPS8L2-1) and control HCT116 (shNC) cells were used for CUT&amp;Tag assay according to the protocol of Hyperactive Universal CUT&amp;Tag Assay Kit for Illumina Pro (Vazyme, #TD904-01/02). 2â€‰Ã—â€‰10<sup>5</sup> cells were harvested for each reaction. Anti-YBX1 antibody (Huabio, # ET1609-10, 1:50) was used as primary antibodies. Libraries were tested by Agilent 2100 bioanalyzer. All CUT&amp;Tag libraries were sequenced by Novogene using Illumina NovaSeq XPlus platform in PE150 mode. Quality control of the raw CUT&amp;Tag data was performed using FastQC, followed by low-quality base trimming from the fastq files using Trim_Galore v0.6.10. The data were aligned to the reference genome using Bowtie2. Paired-end reads were converted into paired BED files using samtools view, and duplicate reads were removed using samtools rmdup for downstream analysis. Peak calling was conducted using MACS2 v2.2.7.1. Differential peak analysis between groups was performed using Macs2 bdgdiff, and peaks were visualized and rendered using Integrative Genomics Viewer (IGV v2.16.0). Each peak was annotated using bedtools intersect based on GENCODE gene annotation. Heatmap were generated using deepTools computeMatrix.</p></section><section id="Sec31"><h3 class="pmc_sec_title">Luciferase reporter assay</h3>
<p id="Par45">The promoter sequence of G3BP2 was cloned into pGL3-basic vector. Luciferase reporter plasmid, shEPS8L2, oeEPS8L2, shYBX1, oeYBX1 plasmid, or negative control plasmid were co-transfected into HEK293T cells using jetPRIME transfection reagent. After 48â€‰h, the cells were lysed and prepared according to Dual Luciferase Reporter Gene Assay Kit (Beyotime, #RG027). Renilla luciferase activity as an internal control. The primers are listed in Supplementary Table <a href="#MOESM1" class="usa-link">2</a>.</p></section><section id="Sec32"><h3 class="pmc_sec_title">Chromatin Immunoprecipitation assay</h3>
<p id="Par46">2â€‰Ã—â€‰10<sup>7</sup> HEK293T cells were collected and cross-linked with 1% formaldehyde at room temperature for 10â€‰min. Next, quenched with 2.5â€‰M glycine at room temperature for 5â€‰min and lysed in SDS lysis buffer on ice for 10â€‰min. Chromatin was sonicated (200â€‰W, 30â€‰s on/60â€‰s off, 5 cycles) and fragment size verified by agarose gel electrophoresis. After centrifugation at 14,000â€‰rpm at 4â€‰Â°C for 10â€‰min, the supernatant was diluted 10-fold in ChIP dilution buffer. Non-specific binding was pre-cleared with Protein A/G beads 50â€‰Î¼L at 4â€‰Â°C for 1â€‰h. The pre-cleared lysate was divided equally: one half incubated with control IgG (2 Î¼g), the other with anti-YBX1 antibody (2â€‰Î¼g) at 4â€‰Â°C for overnight. 50 Î¼L Protein A/G beads were added at 4â€‰Â°C for 4â€‰h to capture immunocomplexes. Beads were washed sequentially with low salt, high salt, LiCl, and TE buffers. Bound complexes were eluted with Elution Buffer 500â€‰Î¼L at room temperature for 15â€‰min. Eluates were de-crosslinked with 5â€‰M NaCl at 65â€‰Â°C for 4â€‰h, and proteins digested with proteinase K at 45â€‰Â°C for 2â€‰h. DNA was purified by phenol-chloroform and dissolved in nuclease-free water for qPCR analysis using primers from Supplementary Table <a href="#MOESM1" class="usa-link">6</a>.</p></section><section id="Sec33"><h3 class="pmc_sec_title">Patient-derived organoids (PDOs) isolation and treatment</h3>
<p id="Par47">Freshly resected tumor tissue was immediately placed in ice-cold RPMI-1640 medium and processed within 30â€‰min. Superficial mucosa was carefully removed using scissors. The tissue was then washed vigorously 5â€“10 times with HBSS until blood residues were removed. The washed tissue was minced finely with scissors in 5â€‰mL tube, transferred to 15â€‰mL centrifuge tube, and digested with 6â€‰mL of pre-warmed digestion solution at 37â€‰Â°C under gentle agitation. Digestion progress was briefly monitored microscopically after 10â€‰min. Digestion was terminated by adding 3 times volume of ice-cold DPBS, followed by vigorous pipetting 20â€“30 times. The resulting cell suspension was filtered through a 70â€‰Î¼m cell strainer. The filtrate was centrifuged at 300â€‰Ã—â€‰<em>g</em> for 5â€‰min at 4â€‰Â°C. The supernatant was discarded, and the cell pellet was resuspended in organoid culture medium (DIMED, K211M01) to an appropriate density. The cell suspension was then mixed with Matrigelâ„¢ at a 1:2 ratio. Aliquots of the cell-Matrigel mixture were plated in 48-well plate and solidified for 15â€‰min at 37â€‰Â°C. Finally, 300 Î¼L of pre-warmed organoid culture medium was added to each well, and cultures were maintained in incubator.</p></section><section id="Sec34"><h3 class="pmc_sec_title">Immunofluorescence (IF) assay</h3>
<p id="Par48">Cells on coverslips were washed twice with PBS and fixed in 4% paraformaldehyde (PFA) for 10â€‰min at room temperature. After PBS washing, cells were permeabilized with 1% Triton X-100 for 20â€‰min at room temperature and blocked with 10% goat serum for 30â€‰min at room temperature. Subsequently, samples were incubated overnight at 4â€‰Â°C with primary antibody EPS8L2 and YBX1. Next day, samples were incubated with HRP-conjugated secondary antibody for 1â€‰h at room temperature, followed by Tyramide Signal Amplification (TSA) reaction according to manufacturerâ€™s protocols (Aifang Bio, Cat# AFIHC036). Nuclei were counterstained with DAPI for 5â€‰min at room temperature. Finally, the slides were sealed with anti-fluorescence quenching sealer (Cat# S2100, Solarbio).</p></section><section id="Sec35"><h3 class="pmc_sec_title">Statistical analysis</h3>
<p id="Par49">The results were analyzed using GraphPad Prism 8 and R 4.3.2. The data from both groups were normally distributed, and <em>p</em> values between the two groups were calculated using two-tailed paired or unpaired Studentâ€™s t-tests when the variances were similar. Data that did not conform to normal distribution were analyzed using nonparametric tests. The variance dissimilar between groups were analyzed by Welchâ€™s correction. One-way ANOVA was used for multiple group comparisons. Two-way ANOVA was used to calculate the statistical significances of cell proliferation and tumor growth in different groups. <em>P</em> values of survival analysis were calculated using log rank tests. Gene correlation analysis in R was assessed using Pearsonâ€™s test. The sample size was not determined based on a priori statistical calculations, and no data were excluded during analysis. Each experiment was independently performed at least three times. All values were expressed as mean valuesâ€‰Â±â€‰SD. In all statistical analyses, <em>p</em> values of &lt;0.05 were considered statistically significant (*<em>p</em>â€‰&lt;â€‰0.05, **<em>p</em>â€‰&lt;â€‰0.01, ***<em>p</em>â€‰&lt;â€‰0.001, ns indicates no significant difference).</p></section><section id="Sec36"><h3 class="pmc_sec_title">Accession numbers</h3>
<p id="Par50">Raw RNA-sequence data have been deposited in the NCBI Sequence Read Archive (SUB15382866, accession code: PRJNA1275751).</p></section></section><section id="Sec37"><h2 class="pmc_sec_title">Supplementary information</h2>
<section class="sm xbox font-sm" id="MOESM1"><div class="media p"><div class="caption">
<a href="/articles/instance/12335500/bin/41419_2025_7929_MOESM1_ESM.docx" data-ga-action="click_feat_suppl" class="usa-link">Supplementary materials</a><sup> (1.7MB, docx) </sup>
</div></div></section><section class="sm xbox font-sm" id="MOESM2"><div class="media p"><div class="caption">
<a href="/articles/instance/12335500/bin/41419_2025_7929_MOESM2_ESM.pdf" data-ga-action="click_feat_suppl" class="usa-link">uncropped western blots</a><sup> (7.8MB, pdf) </sup>
</div></div></section><section class="sm xbox font-sm" id="MOESM3"><div class="media p"><div class="caption">
<a href="/articles/instance/12335500/bin/41419_2025_7929_MOESM3_ESM.xlsx" data-ga-action="click_feat_suppl" class="usa-link">RT-qPCR original data</a><sup> (15.9KB, xlsx) </sup>
</div></div></section></section><section id="ack1" class="ack"><h2 class="pmc_sec_title">Acknowledgements</h2>
<p>This work was supported by Outstanding Youth Project of the Natural Science Foundation of Henan Province (252300421019), Joint Funding of Henan Provincial Science and Technology R&amp;D Plan (222301420015), National Natural Science Foundation of China (82371826, 32170874, 82203490), Scientific and Technological Research Project of Henan Province (242102311145), Natural Science Foundation of Henan province (242300420380).</p></section><section id="notes1"><h2 class="pmc_sec_title">Author contributions</h2>
<p>Y.D. and P.L. performed experiments, analyzed data, and wrote the paper; Y.Y., G.W., H.X., L.L., and X.S. performed some experiments and analyzed data; H.C. and L.Z. collected and processed human samples; S.J. provided human samples and revised the paper; B.L. and L.H. initiated the study, organized, designed, and revised the paper.</p></section><section id="notes2"><h2 class="pmc_sec_title">Data availability</h2>
<p>All data are available upon reasonable request.</p></section><section id="FPar1"><h2 class="pmc_sec_title">Competing interests</h2>
<p id="Par51">The authors declare no competing interests.</p></section><section id="FPar2"><h2 class="pmc_sec_title">Ethics approval and consent to participate</h2>
<p id="Par52">All methods were performed in accordance with the relevant guidelines and regulations, and approved by laboratory animal platform of Academy of Medical Sciences of Zhengzhou University (No. ZZUIRB2023-320). Human colorectal cancer specimens were obtained from the Department of Oncology, the First Affiliated Hospital of Zhengzhou University with informed consent, according to the Institutional Review Board approval.</p></section><section id="fn-group1" class="fn-group"><h2 class="pmc_sec_title">Footnotes</h2>
<div class="fn-group p font-secondary-light font-sm">
<div class="fn p" id="fn1"><p>Edited by Professor Anastasis Stephanou</p></div>
<div class="fn p" id="fn2"><p><strong>Publisherâ€™s note</strong> Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p></div>
<div class="fn p" id="fn3"><p>These authors contributed equally: Yimeng Duan, Peixian Li.</p></div>
</div></section><section id="_ci93_" lang="en" class="contrib-info"><h2 class="pmc_sec_title">Contributor Information</h2>
<p>Shuiling Jin, Email: fccjinsl@zzu.edu.cn.</p>
<p>Luyun He, Email: hly2020@zzu.edu.cn.</p>
<p>Benyu Liu, Email: benyuliu@zzu.edu.cn.</p></section><section id="sec38"><h2 class="pmc_sec_title">Supplementary information</h2>
<p>The online version contains supplementary material available at 10.1038/s41419-025-07929-x.</p></section><section id="Bib1" class="ref-list"><h2 class="pmc_sec_title">References</h2>
<section id="Bib1_sec2"><ul class="ref-list font-sm" style="list-style-type:none">
<li id="CR1">
<span class="label">1.</span><cite>Siegel RL, Giaquinto AN, Jemal A. Cancer statistics, 2024. CA Cancer J Clin. 2024;74:12â€“49.
</cite> [<a href="https://doi.org/10.3322/caac.21820" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38230766/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Siegel%20RL,%20Giaquinto%20AN,%20Jemal%20A.%20Cancer%20statistics,%202024.%20CA%20Cancer%20J%20Clin.%202024;74:12%E2%80%9349." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR2">
<span class="label">2.</span><cite>Amodio V, Vitiello PP, Bardelli A, Germano G. DNA repair-dependent immunogenic liabilities in colorectal cancer: opportunities from errors. Br J Cancer. 2024;131:1576â€“90.</cite> [<a href="https://doi.org/10.1038/s41416-024-02848-8" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC11554791/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/39271762/" class="usa-link">PubMed</a>]</li>
<li id="CR3">
<span class="label">3.</span><cite>Yang L, Yang J, Kleppe A, Danielsen HE, Kerr DJ. Personalizing adjuvant therapy for patients with colorectal cancer. Nat Rev Clin Oncol. 2024;21:67â€“79.
</cite> [<a href="https://doi.org/10.1038/s41571-023-00834-2" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38001356/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Yang%20L,%20Yang%20J,%20Kleppe%20A,%20Danielsen%20HE,%20Kerr%20DJ.%20Personalizing%20adjuvant%20therapy%20for%20patients%20with%20colorectal%20cancer.%20Nat%20Rev%20Clin%20Oncol.%202024;21:67%E2%80%9379." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR4">
<span class="label">4.</span><cite>Canellas-Socias A, Sancho E, Batlle E. Mechanisms of metastatic colorectal cancer. Nat Rev Gastroenterol Hepatol. 2024;21:609â€“25.
</cite> [<a href="https://doi.org/10.1038/s41575-024-00934-z" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38806657/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Canellas-Socias%20A,%20Sancho%20E,%20Batlle%20E.%20Mechanisms%20of%20metastatic%20colorectal%20cancer.%20Nat%20Rev%20Gastroenterol%20Hepatol.%202024;21:609%E2%80%9325." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR5">
<span class="label">5.</span><cite>Bien J, Lin A. A review of the diagnosis and treatment of metastatic colorectal cancer. JAMA. 2021;325:2404â€“5.
</cite> [<a href="https://doi.org/10.1001/jama.2021.6021" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34129003/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Bien%20J,%20Lin%20A.%20A%20review%20of%20the%20diagnosis%20and%20treatment%20of%20metastatic%20colorectal%20cancer.%20JAMA.%202021;325:2404%E2%80%935." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR6">
<span class="label">6.</span><cite>Tomuleasa C, Tigu AB, Munteanu R, Moldovan CS, Kegyes D, Onaciu A, et al. Therapeutic advances of targeting receptor tyrosine kinases in cancer. Signal Transduct Target Ther. 2024;9:201.
</cite> [<a href="https://doi.org/10.1038/s41392-024-01899-w" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC11323831/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/39138146/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Tomuleasa%20C,%20Tigu%20AB,%20Munteanu%20R,%20Moldovan%20CS,%20Kegyes%20D,%20Onaciu%20A,%20et%20al.%20Therapeutic%20advances%20of%20targeting%20receptor%20tyrosine%20kinases%20in%20cancer.%20Signal%20Transduct%20Target%20Ther.%202024;9:201." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR7">
<span class="label">7.</span><cite>Paul MD, Hristova K. The RTK Interactome: overview and Perspective on RTK Heterointeractions. Chem Rev. 2019;119:5881â€“921.
</cite> [<a href="https://doi.org/10.1021/acs.chemrev.8b00467" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6918702/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30589534/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Paul%20MD,%20Hristova%20K.%20The%20RTK%20Interactome:%20overview%20and%20Perspective%20on%20RTK%20Heterointeractions.%20Chem%20Rev.%202019;119:5881%E2%80%93921." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR8">
<span class="label">8.</span><cite>Huang L, Jiang S, Shi Y. Tyrosine kinase inhibitors for solid tumors in the past 20 years (2001-2020). J Hematol Oncol. 2020;13:143.
</cite> [<a href="https://doi.org/10.1186/s13045-020-00977-0" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7590700/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33109256/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Huang%20L,%20Jiang%20S,%20Shi%20Y.%20Tyrosine%20kinase%20inhibitors%20for%20solid%20tumors%20in%20the%20past%2020%20years%20(2001-2020).%20J%20Hematol%20Oncol.%202020;13:143." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR9">
<span class="label">9.</span><cite>Perurena N, Situ L, Cichowski K. Combinatorial strategies to target RAS-driven cancers. Nat Rev Cancer. 2024;24:316â€“37.
</cite> [<a href="https://doi.org/10.1038/s41568-024-00679-6" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38627557/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Perurena%20N,%20Situ%20L,%20Cichowski%20K.%20Combinatorial%20strategies%20to%20target%20RAS-driven%20cancers.%20Nat%20Rev%20Cancer.%202024;24:316%E2%80%9337." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR10">
<span class="label">10.</span><cite>Castel P, Toska E, Engelman JA, Scaltriti M. The present and future of PI3K inhibitors for cancer therapy. Nat Cancer. 2021;2:587â€“97.
</cite> [<a href="https://doi.org/10.1038/s43018-021-00218-4" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8809509/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35118422/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Castel%20P,%20Toska%20E,%20Engelman%20JA,%20Scaltriti%20M.%20The%20present%20and%20future%20of%20PI3K%20inhibitors%20for%20cancer%20therapy.%20Nat%20Cancer.%202021;2:587%E2%80%9397." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR11">
<span class="label">11.</span><cite>Fazioli F, Minichiello L, Matoska V, Castagnino P, Miki T, Wong WT, et al. Eps8, a substrate for the epidermal growth factor receptor kinase, enhances EGF-dependent mitogenic signals. EMBO J. 1993;12:3799â€“808.
</cite> [<a href="https://doi.org/10.1002/j.1460-2075.1993.tb06058.x" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC413663/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/8404850/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Fazioli%20F,%20Minichiello%20L,%20Matoska%20V,%20Castagnino%20P,%20Miki%20T,%20Wong%20WT,%20et%20al.%20Eps8,%20a%20substrate%20for%20the%20epidermal%20growth%20factor%20receptor%20kinase,%20enhances%20EGF-dependent%20mitogenic%20signals.%20EMBO%20J.%201993;12:3799%E2%80%93808." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR12">
<span class="label">12.</span><cite>Offenhauser N, Borgonovo A, Disanza A, Romano P, Ponzanelli I, Iannolo G, et al. The eps8 family of proteins links growth factor stimulation to actin reorganization generating functional redundancy in the Ras/Rac pathway. Mol Biol Cell. 2004;15:91â€“8.
</cite> [<a href="https://doi.org/10.1091/mbc.E03-06-0427" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC307530/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/14565974/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Offenhauser%20N,%20Borgonovo%20A,%20Disanza%20A,%20Romano%20P,%20Ponzanelli%20I,%20Iannolo%20G,%20et%20al.%20The%20eps8%20family%20of%20proteins%20links%20growth%20factor%20stimulation%20to%20actin%20reorganization%20generating%20functional%20redundancy%20in%20the%20Ras/Rac%20pathway.%20Mol%20Biol%20Cell.%202004;15:91%E2%80%938." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR13">
<span class="label">13.</span><cite>Li M, Yang J, Zhang L, Tu S, Zhou X, Tan Z, et al. A low-molecular-weight compound exerts anticancer activity against breast and lung cancers by disrupting EGFR/Eps8 complex formation. J Exp Clin Cancer Res. 2019;38:211.
</cite> [<a href="https://doi.org/10.1186/s13046-019-1207-y" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6532146/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31118055/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Li%20M,%20Yang%20J,%20Zhang%20L,%20Tu%20S,%20Zhou%20X,%20Tan%20Z,%20et%20al.%20A%20low-molecular-weight%20compound%20exerts%20anticancer%20activity%20against%20breast%20and%20lung%20cancers%20by%20disrupting%20EGFR/Eps8%20complex%20formation.%20J%20Exp%20Clin%20Cancer%20Res.%202019;38:211." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR14">
<span class="label">14.</span><cite>Shahoumi LA, Khodadadi H, Bensreti H, Baban B, Yeudall WA. EPS8 phosphorylation by Src modulates its oncogenic functions. Br J Cancer. 2020;123:1078â€“88.
</cite> [<a href="https://doi.org/10.1038/s41416-020-0976-6" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7525440/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32641864/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Shahoumi%20LA,%20Khodadadi%20H,%20Bensreti%20H,%20Baban%20B,%20Yeudall%20WA.%20EPS8%20phosphorylation%20by%20Src%20modulates%20its%20oncogenic%20functions.%20Br%20J%20Cancer.%202020;123:1078%E2%80%9388." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR15">
<span class="label">15.</span><cite>Xuan Z, Zhao L, Li Z, Song W, Chen J, Chen J, et al. EPS8L3 promotes hepatocellular carcinoma proliferation and metastasis by modulating EGFR dimerization and internalization. Am J Cancer Res. 2020;10:60â€“77.
</cite> [<a href="/articles/PMC7017737/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32064153/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Xuan%20Z,%20Zhao%20L,%20Li%20Z,%20Song%20W,%20Chen%20J,%20Chen%20J,%20et%20al.%20EPS8L3%20promotes%20hepatocellular%20carcinoma%20proliferation%20and%20metastasis%20by%20modulating%20EGFR%20dimerization%20and%20internalization.%20Am%20J%20Cancer%20Res.%202020;10:60%E2%80%9377." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR16">
<span class="label">16.</span><cite>Furness DN, Johnson SL, Manor U, Ruttiger L, Tocchetti A, Offenhauser N, et al. Progressive hearing loss and gradual deterioration of sensory hair bundles in the ears of mice lacking the actin-binding protein Eps8L2. Proc Natl Acad Sci USA. 2013;110:13898â€“903.
</cite> [<a href="https://doi.org/10.1073/pnas.1304644110" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3752214/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/23918390/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Furness%20DN,%20Johnson%20SL,%20Manor%20U,%20Ruttiger%20L,%20Tocchetti%20A,%20Offenhauser%20N,%20et%20al.%20Progressive%20hearing%20loss%20and%20gradual%20deterioration%20of%20sensory%20hair%20bundles%20in%20the%20ears%20of%20mice%20lacking%20the%20actin-binding%20protein%20Eps8L2.%20Proc%20Natl%20Acad%20Sci%20USA.%202013;110:13898%E2%80%93903." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR17">
<span class="label">17.</span><cite>Dahmani M, Ammar-Khodja F, Bonnet C, Lefevre GM, Hardelin JP, Ibrahim H, et al. EPS8L2 is a new causal gene for childhood onset autosomal recessive progressive hearing loss. Orphanet J Rare Dis. 2015;10:96.
</cite> [<a href="https://doi.org/10.1186/s13023-015-0316-8" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4539681/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/26282398/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Dahmani%20M,%20Ammar-Khodja%20F,%20Bonnet%20C,%20Lefevre%20GM,%20Hardelin%20JP,%20Ibrahim%20H,%20et%20al.%20EPS8L2%20is%20a%20new%20causal%20gene%20for%20childhood%20onset%20autosomal%20recessive%20progressive%20hearing%20loss.%20Orphanet%20J%20Rare%20Dis.%202015;10:96." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR18">
<span class="label">18.</span><cite>Yan K, Zong W, Du H, Zhai X, Ren R, Liu S, et al. BAIAP2L2 is required for the maintenance of mechanotransducing stereocilia of cochlear hair cells. J Cell Physiol. 2022;237:774â€“88.
</cite> [<a href="https://doi.org/10.1002/jcp.30545" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34346063/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Yan%20K,%20Zong%20W,%20Du%20H,%20Zhai%20X,%20Ren%20R,%20Liu%20S,%20et%20al.%20BAIAP2L2%20is%20required%20for%20the%20maintenance%20of%20mechanotransducing%20stereocilia%20of%20cochlear%20hair%20cells.%20J%20Cell%20Physiol.%202022;237:774%E2%80%9388." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR19">
<span class="label">19.</span><cite>OffenhÃ¤user N. The Eps8 family of proteins links growth factor stimulation to actin reorganization generating functional redundancy in the Ras/Rac pathway. Mol Biol Cell. 2019;30:2535â€“35.
</cite> [<a href="https://doi.org/10.1091/mbc.E03-06-0427" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC307530/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/14565974/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Offenh%C3%A4user%20N.%20The%20Eps8%20family%20of%20proteins%20links%20growth%20factor%20stimulation%20to%20actin%20reorganization%20generating%20functional%20redundancy%20in%20the%20Ras/Rac%20pathway.%20Mol%20Biol%20Cell.%202019;30:2535%E2%80%9335." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR20">
<span class="label">20.</span><cite>Zuo X, Kwon SH, Janech MG, Dang Y, Lauzon SD, Fogelgren B, et al. Primary cilia and the exocyst are linked to urinary extracellular vesicle production and content. J Biol Chem. 2019;294:19099â€“110.
</cite> [<a href="https://doi.org/10.1074/jbc.RA119.009297" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6916495/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31694916/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Zuo%20X,%20Kwon%20SH,%20Janech%20MG,%20Dang%20Y,%20Lauzon%20SD,%20Fogelgren%20B,%20et%20al.%20Primary%20cilia%20and%20the%20exocyst%20are%20linked%20to%20urinary%20extracellular%20vesicle%20production%20and%20content.%20J%20Biol%20Chem.%202019;294:19099%E2%80%93110." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR21">
<span class="label">21.</span><cite>Calero-Cuenca FJ, Osorio DS, Carvalho-Marques S, Sridhara SC, Oliveira LM, Jiao Y, et al. Ctdnep1 and Eps8L2 regulate dorsal actin cables for nuclear positioning during cell migration. Curr Biol. 2021;31:1521â€“30.e1528.
</cite> [<a href="https://doi.org/10.1016/j.cub.2021.01.007" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8043254/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33567288/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Calero-Cuenca%20FJ,%20Osorio%20DS,%20Carvalho-Marques%20S,%20Sridhara%20SC,%20Oliveira%20LM,%20Jiao%20Y,%20et%20al.%20Ctdnep1%20and%20Eps8L2%20regulate%20dorsal%20actin%20cables%20for%20nuclear%20positioning%20during%20cell%20migration.%20Curr%20Biol.%202021;31:1521%E2%80%9330.e1528." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR22">
<span class="label">22.</span><cite>Kesti T, Ruppelt A, Wang JH, Liss M, Wagner R, TaskÃ©n K, et al. Reciprocal regulation of SH3 and SH2 domain binding via tyrosine phosphorylation of a common site in CD3Îµ. J Immunol. 2007;179:878â€“85.
</cite> [<a href="https://doi.org/10.4049/jimmunol.179.2.878" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/17617578/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Kesti%20T,%20Ruppelt%20A,%20Wang%20JH,%20Liss%20M,%20Wagner%20R,%20Task%C3%A9n%20K,%20et%20al.%20Reciprocal%20regulation%20of%20SH3%20and%20SH2%20domain%20binding%20via%20tyrosine%20phosphorylation%20of%20a%20common%20site%20in%20CD3%CE%B5.%20J%20Immunol.%202007;179:878%E2%80%9385." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR23">
<span class="label">23.</span><cite>Ghasemi M, Kalantari S, Zubarev RA, Nafar M, Saei AA, Heidari SS, et al. Predictive biomarker panel in proliferative lupus nephritis, two-dimensional shotgun. Iran J Kidney Dis. 2021;15:121â€“33.
</cite> [<a href="https://pubmed.ncbi.nlm.nih.gov/33764323/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Ghasemi%20M,%20Kalantari%20S,%20Zubarev%20RA,%20Nafar%20M,%20Saei%20AA,%20Heidari%20SS,%20et%20al.%20Predictive%20biomarker%20panel%20in%20proliferative%20lupus%20nephritis,%20two-dimensional%20shotgun.%20Iran%20J%20Kidney%20Dis.%202021;15:121%E2%80%9333." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR24">
<span class="label">24.</span><cite>Meng QJ, Chen YW, Cui LG, Wei YS, Li T, Yuan PH. Comprehensive analysis of biological landscape of oxidative stress-related genes in diabetic erectile dysfunction. Int J Impot Res. 2024;36:627â€“35.
</cite> [<a href="https://doi.org/10.1038/s41443-023-00814-1" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38145980/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Meng%20QJ,%20Chen%20YW,%20Cui%20LG,%20Wei%20YS,%20Li%20T,%20Yuan%20PH.%20Comprehensive%20analysis%20of%20biological%20landscape%20of%20oxidative%20stress-related%20genes%20in%20diabetic%20erectile%20dysfunction.%20Int%20J%20Impot%20Res.%202024;36:627%E2%80%9335." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR25">
<span class="label">25.</span><cite>Kerley-Hamilton JS, Pike AM, Li N, DiRenzo J, Spinella MJ. A p53-dominant transcriptional response to cisplatin in testicular germ cell tumor-derived human embryonal carcinoma. Oncogene. 2005;24:6090â€“6100.
</cite> [<a href="https://doi.org/10.1038/sj.onc.1208755" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/15940259/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Kerley-Hamilton%20JS,%20Pike%20AM,%20Li%20N,%20DiRenzo%20J,%20Spinella%20MJ.%20A%20p53-dominant%20transcriptional%20response%20to%20cisplatin%20in%20testicular%20germ%20cell%20tumor-derived%20human%20embryonal%20carcinoma.%20Oncogene.%202005;24:6090%E2%80%936100." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR26">
<span class="label">26.</span><cite>Colas E, Perez C, Cabrera S, Pedrola N, Monge M, Castellvi J, et al. Molecular markers of endometrial carcinoma detected in uterine aspirates. Int J Cancer. 2011;129:2435â€“44.
</cite> [<a href="https://doi.org/10.1002/ijc.25901" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/21207424/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Colas%20E,%20Perez%20C,%20Cabrera%20S,%20Pedrola%20N,%20Monge%20M,%20Castellvi%20J,%20et%20al.%20Molecular%20markers%20of%20endometrial%20carcinoma%20detected%20in%20uterine%20aspirates.%20Int%20J%20Cancer.%202011;129:2435%E2%80%9344." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR27">
<span class="label">27.</span><cite>Di Meo A, Batruch I, Brown MD, Yang C, Finelli A, Jewett MA, et al. Searching for prognostic biomarkers for small renal masses in the urinary proteome. Int J Cancer. 2020;146:2315â€“25.
</cite> [<a href="https://doi.org/10.1002/ijc.32650" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31465112/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Di%20Meo%20A,%20Batruch%20I,%20Brown%20MD,%20Yang%20C,%20Finelli%20A,%20Jewett%20MA,%20et%20al.%20Searching%20for%20prognostic%20biomarkers%20for%20small%20renal%20masses%20in%20the%20urinary%20proteome.%20Int%20J%20Cancer.%202020;146:2315%E2%80%9325." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR28">
<span class="label">28.</span><cite>Xu N, Yu Y, Duan C, Wei J, Sun W, Jiang C, et al. Quantitative proteomics identifies and validates urinary biomarkers of rhabdomyosarcoma in children. Clin Proteom. 2023;20:10.</cite> [<a href="https://doi.org/10.1186/s12014-023-09401-4" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10012572/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36918772/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Xu%20N,%20Yu%20Y,%20Duan%20C,%20Wei%20J,%20Sun%20W,%20Jiang%20C,%20et%20al.%20Quantitative%20proteomics%20identifies%20and%20validates%20urinary%20biomarkers%20of%20rhabdomyosarcoma%20in%20children.%20Clin%20Proteom.%202023;20:10." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR29">
<span class="label">29.</span><cite>Mitchell AV, Wu L, James Block C, Zhang M, Hackett J, Craig DB, et al. FOXQ1 recruits the MLL complex to activate transcription of EMT and promote breast cancer metastasis. Nat Commun. 2022;13:6548.
</cite> [<a href="https://doi.org/10.1038/s41467-022-34239-z" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9626503/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36319643/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Mitchell%20AV,%20Wu%20L,%20James%20Block%20C,%20Zhang%20M,%20Hackett%20J,%20Craig%20DB,%20et%20al.%20FOXQ1%20recruits%20the%20MLL%20complex%20to%20activate%20transcription%20of%20EMT%20and%20promote%20breast%20cancer%20metastasis.%20Nat%20Commun.%202022;13:6548." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR30">
<span class="label">30.</span><cite>Song F, Zhang Z, Liu W, Xu T, Hu X, Wang Q, et al. Peptide transporter 1-mediated dipeptide transport promotes hepatocellular carcinoma metastasis by activating MAP4K4/G3BP2 signaling axis. Adv Sci. 2024;11:e2306671.</cite> [<a href="https://doi.org/10.1002/advs.202306671" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC11200092/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38639383/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Song%20F,%20Zhang%20Z,%20Liu%20W,%20Xu%20T,%20Hu%20X,%20Wang%20Q,%20et%20al.%20Peptide%20transporter%201-mediated%20dipeptide%20transport%20promotes%20hepatocellular%20carcinoma%20metastasis%20by%20activating%20MAP4K4/G3BP2%20signaling%20axis.%20Adv%20Sci.%202024;11:e2306671." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR31">
<span class="label">31.</span><cite>Evers M, Stuhmer T, Schreder M, Steinbrunn T, Rudelius M, Jundt F, et al. Association of ADAM family members with proliferation signaling and disease progression in multiple myeloma. Blood Cancer J. 2024;14:156.
</cite> [<a href="https://doi.org/10.1038/s41408-024-01133-4" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC11390935/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/39261477/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Evers%20M,%20Stuhmer%20T,%20Schreder%20M,%20Steinbrunn%20T,%20Rudelius%20M,%20Jundt%20F,%20et%20al.%20Association%20of%20ADAM%20family%20members%20with%20proliferation%20signaling%20and%20disease%20progression%20in%20multiple%20myeloma.%20Blood%20Cancer%20J.%202024;14:156." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR32">
<span class="label">32.</span><cite>Primeaux M, Liu X, Gowrikumar S, Fatima I, Fisher KW, Bastola D, et al. Claudin-1 interacts with EPHA2 to promote cancer stemness and chemoresistance in colorectal cancer. Cancer Lett. 2023;579:216479.
</cite> [<a href="https://doi.org/10.1016/j.canlet.2023.216479" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10765961/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37924938/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Primeaux%20M,%20Liu%20X,%20Gowrikumar%20S,%20Fatima%20I,%20Fisher%20KW,%20Bastola%20D,%20et%20al.%20Claudin-1%20interacts%20with%20EPHA2%20to%20promote%20cancer%20stemness%20and%20chemoresistance%20in%20colorectal%20cancer.%20Cancer%20Lett.%202023;579:216479." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR33">
<span class="label">33.</span><cite>Tiwari A, Tashiro K, Dixit A, Soni A, Vogel K, Hall B, et al. Loss of HIF1A from pancreatic cancer cells increases expression of PPP1R1B and degradation of p53 to promote invasion and metastasis. Gastroenterology. 2020;159:1882â€“97.e1885.
</cite> [<a href="https://doi.org/10.1053/j.gastro.2020.07.046" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7680408/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32768595/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Tiwari%20A,%20Tashiro%20K,%20Dixit%20A,%20Soni%20A,%20Vogel%20K,%20Hall%20B,%20et%20al.%20Loss%20of%20HIF1A%20from%20pancreatic%20cancer%20cells%20increases%20expression%20of%20PPP1R1B%20and%20degradation%20of%20p53%20to%20promote%20invasion%20and%20metastasis.%20Gastroenterology.%202020;159:1882%E2%80%9397.e1885." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR34">
<span class="label">34.</span><cite>Sun X, Gao C, Xu X, Li M, Zhao X, Wang Y, et al. FBL promotes cancer cell resistance to DNA damage and BRCA1 transcription via YBX1. EMBO Rep. 2023;24:e56230.
</cite> [<a href="https://doi.org/10.15252/embr.202256230" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10481664/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37489617/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Sun%20X,%20Gao%20C,%20Xu%20X,%20Li%20M,%20Zhao%20X,%20Wang%20Y,%20et%20al.%20FBL%20promotes%20cancer%20cell%20resistance%20to%20DNA%20damage%20and%20BRCA1%20transcription%20via%20YBX1.%20EMBO%20Rep.%202023;24:e56230." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR35">
<span class="label">35.</span><cite>Jiang W, Wang J, Yang X, Shan J, Zhang Y, Shi X, et al. KIF14 promotes proliferation, lymphatic metastasis and chemoresistance through G3BP1/YBX1 mediated NF-kappaB pathway in cholangiocarcinoma. Oncogene. 2023;42:1392â€“404.
</cite> [<a href="https://doi.org/10.1038/s41388-023-02661-2" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36922675/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Jiang%20W,%20Wang%20J,%20Yang%20X,%20Shan%20J,%20Zhang%20Y,%20Shi%20X,%20et%20al.%20KIF14%20promotes%20proliferation,%20lymphatic%20metastasis%20and%20chemoresistance%20through%20G3BP1/YBX1%20mediated%20NF-kappaB%20pathway%20in%20cholangiocarcinoma.%20Oncogene.%202023;42:1392%E2%80%93404." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR36">
<span class="label">36.</span><cite>Hong X, Li Q, Li J, Chen K, He Q, Zhao Y, et al. CircIPO7 promotes nasopharyngeal carcinoma metastasis and cisplatin chemoresistance by facilitating YBX1 nuclear localization. Clin Cancer Res. 2022;28:4521â€“35.
</cite> [<a href="https://doi.org/10.1158/1078-0432.CCR-22-0991" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35917517/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Hong%20X,%20Li%20Q,%20Li%20J,%20Chen%20K,%20He%20Q,%20Zhao%20Y,%20et%20al.%20CircIPO7%20promotes%20nasopharyngeal%20carcinoma%20metastasis%20and%20cisplatin%20chemoresistance%20by%20facilitating%20YBX1%20nuclear%20localization.%20Clin%20Cancer%20Res.%202022;28:4521%E2%80%9335." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR37">
<span class="label">37.</span><cite>Tiwari A, Rebholz S, Maier E, Dehghan Harati M, Zips D, Sers C, et al. Stress-induced phosphorylation of nuclear YB-1 depends on nuclear trafficking of p90 ribosomal S6 kinase. Int J Mol Sci. 2018;19:2441.</cite> [<a href="https://doi.org/10.3390/ijms19082441" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6121600/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30126195/" class="usa-link">PubMed</a>]</li>
<li id="CR38">
<span class="label">38.</span><cite>Li Z, Xue H, Li J, Zheng Z, Liu Z, Dong X, et al. CDKL1 potentiates the antitumor efficacy of radioimmunotherapy by binding to transcription factor YBX1 and blocking PD-L1 expression in lung cancer. J Exp Clin Cancer Res. 2024;43:89.
</cite> [<a href="https://doi.org/10.1186/s13046-024-03007-w" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10958935/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38520004/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Li%20Z,%20Xue%20H,%20Li%20J,%20Zheng%20Z,%20Liu%20Z,%20Dong%20X,%20et%20al.%20CDKL1%20potentiates%20the%20antitumor%20efficacy%20of%20radioimmunotherapy%20by%20binding%20to%20transcription%20factor%20YBX1%20and%20blocking%20PD-L1%20expression%20in%20lung%20cancer.%20J%20Exp%20Clin%20Cancer%20Res.%202024;43:89." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR39">
<span class="label">39.</span><cite>Bai Y, Gotz C, Chincarini G, Zhao Z, Slaney C, Boath J, et al. YBX1 integration of oncogenic PI3K/mTOR signalling regulates the fitness of malignant epithelial cells. Nat Commun. 2023;14:1591.
</cite> [<a href="https://doi.org/10.1038/s41467-023-37161-0" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10033729/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36949044/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Bai%20Y,%20Gotz%20C,%20Chincarini%20G,%20Zhao%20Z,%20Slaney%20C,%20Boath%20J,%20et%20al.%20YBX1%20integration%20of%20oncogenic%20PI3K/mTOR%20signalling%20regulates%20the%20fitness%20of%20malignant%20epithelial%20cells.%20Nat%20Commun.%202023;14:1591." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR40">
<span class="label">40.</span><cite>Ru J, Lu J, Ge J, Ding B, Su R, Jiang Y, et al. IRGM is a novel regulator of PD-L1 via promoting S6K1-mediated phosphorylation of YBX1 in hepatocellular carcinoma. Cancer Lett. 2024;581:216495.
</cite> [<a href="https://doi.org/10.1016/j.canlet.2023.216495" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37993085/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Ru%20J,%20Lu%20J,%20Ge%20J,%20Ding%20B,%20Su%20R,%20Jiang%20Y,%20et%20al.%20IRGM%20is%20a%20novel%20regulator%20of%20PD-L1%20via%20promoting%20S6K1-mediated%20phosphorylation%20of%20YBX1%20in%20hepatocellular%20carcinoma.%20Cancer%20Lett.%202024;581:216495." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR41">
<span class="label">41.</span><cite>Shibata T, Watari K, Kawahara A, Sudo T, Hattori S, Murakami Y, et al. Targeting phosphorylation of Y-box-binding protein YBX1 by TAS0612 and everolimus in overcoming antiestrogen resistance. Mol Cancer Ther. 2020;19:882â€“94.
</cite> [<a href="https://doi.org/10.1158/1535-7163.MCT-19-0690" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31879363/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Shibata%20T,%20Watari%20K,%20Kawahara%20A,%20Sudo%20T,%20Hattori%20S,%20Murakami%20Y,%20et%20al.%20Targeting%20phosphorylation%20of%20Y-box-binding%20protein%20YBX1%20by%20TAS0612%20and%20everolimus%20in%20overcoming%20antiestrogen%20resistance.%20Mol%20Cancer%20Ther.%202020;19:882%E2%80%9394." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR42">
<span class="label">42.</span><cite>Jin G, Zhang Z, Wan J, Wu X, Liu X, Zhang W. G3BP2: structure and function. Pharmacol Res. 2022;186:106548.
</cite> [<a href="https://doi.org/10.1016/j.phrs.2022.106548" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36336216/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Jin%20G,%20Zhang%20Z,%20Wan%20J,%20Wu%20X,%20Liu%20X,%20Zhang%20W.%20G3BP2:%20structure%20and%20function.%20Pharmacol%20Res.%202022;186:106548." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR43">
<span class="label">43.</span><cite>Alam U, Kennedy D. G3BP1 and G3BP2 regulate translation of interferon-stimulated genes: IFITM1, IFITM2 and IFITM3 in the cancer cell line MCF7. Mol Cell Biochem. 2019;459:189â€“204.
</cite> [<a href="https://doi.org/10.1007/s11010-019-03562-3" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31172368/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Alam%20U,%20Kennedy%20D.%20G3BP1%20and%20G3BP2%20regulate%20translation%20of%20interferon-stimulated%20genes:%20IFITM1,%20IFITM2%20and%20IFITM3%20in%20the%20cancer%20cell%20line%20MCF7.%20Mol%20Cell%20Biochem.%202019;459:189%E2%80%93204." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR44">
<span class="label">44.</span><cite>Cornish, Gruber AJ, Kinnersley AJ, Chubb B, Frangou D, Caravagna G A, et al. The genomic landscape of 2,023 colorectal cancers. Nature. 2024;633:127â€“36.
</cite> [<a href="https://doi.org/10.1038/s41586-024-07747-9" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC11374690/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/39112709/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Cornish,%20Gruber%20AJ,%20Kinnersley%20AJ,%20Chubb%20B,%20Frangou%20D,%20Caravagna%20G%20A,%20et%20al.%20The%20genomic%20landscape%20of%202,023%20colorectal%20cancers.%20Nature.%202024;633:127%E2%80%9336." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR45">
<span class="label">45.</span><cite>Hindson J. Characterizing the genomic landscape of colorectal cancer. Nat Rev Gastroenterol Hepatol. 2024;21:667.
</cite> [<a href="https://doi.org/10.1038/s41575-024-00988-z" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/39251707/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Hindson%20J.%20Characterizing%20the%20genomic%20landscape%20of%20colorectal%20cancer.%20Nat%20Rev%20Gastroenterol%20Hepatol.%202024;21:667." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR46">
<span class="label">46.</span><cite>Riaud M, Maxwell J, Soria-Bretones I, Dankner M, Li M, Rose AAN. The role of CRAF in cancer progression: from molecular mechanisms to precision therapies. Nat Rev Cancer. 2024;24:105â€“22.
</cite> [<a href="https://doi.org/10.1038/s41568-023-00650-x" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38195917/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Riaud%20M,%20Maxwell%20J,%20Soria-Bretones%20I,%20Dankner%20M,%20Li%20M,%20Rose%20AAN.%20The%20role%20of%20CRAF%20in%20cancer%20progression:%20from%20molecular%20mechanisms%20to%20precision%20therapies.%20Nat%20Rev%20Cancer.%202024;24:105%E2%80%9322." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR47">
<span class="label">47.</span><cite>Shen H, Yuan J, Tong D, Chen B, Yu E, Chen G, et al. Regulator of G protein signaling 16 restrains apoptosis in colorectal cancer through disrupting TRAF6-TAB2-TAK1-JNK/p38 MAPK signaling. Cell Death Dis. 2024;15:438.
</cite> [<a href="https://doi.org/10.1038/s41419-024-06803-6" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC11192724/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38906869/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Shen%20H,%20Yuan%20J,%20Tong%20D,%20Chen%20B,%20Yu%20E,%20Chen%20G,%20et%20al.%20Regulator%20of%20G%20protein%20signaling%2016%20restrains%20apoptosis%20in%20colorectal%20cancer%20through%20disrupting%20TRAF6-TAB2-TAK1-JNK/p38%20MAPK%20signaling.%20Cell%20Death%20Dis.%202024;15:438." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR48">
<span class="label">48.</span><cite>Di Y, Zhang X, Wen X, Qin J, Ye L, Wang Y, et al. MAPK signaling-mediated RFNG phosphorylation and nuclear translocation restrain oxaliplatin-induced apoptosis and ferroptosis. Adv Sci. 2024;11:e2402795.</cite> [<a href="https://doi.org/10.1002/advs.202402795" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC11481204/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/39120977/" class="usa-link">PubMed</a>]</li>
<li id="CR49">
<span class="label">49.</span><cite>Li B, Xing F, Wang J, Wang X, Zhou C, Fan G, et al. YBX1 as a therapeutic target to suppress the LRP1-beta-catenin-RRM1 axis and overcome gemcitabine resistance in pancreatic cancer. Cancer Lett. 2024;602:217197.
</cite> [<a href="https://doi.org/10.1016/j.canlet.2024.217197" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/39216548/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Li%20B,%20Xing%20F,%20Wang%20J,%20Wang%20X,%20Zhou%20C,%20Fan%20G,%20et%20al.%20YBX1%20as%20a%20therapeutic%20target%20to%20suppress%20the%20LRP1-beta-catenin-RRM1%20axis%20and%20overcome%20gemcitabine%20resistance%20in%20pancreatic%20cancer.%20Cancer%20Lett.%202024;602:217197." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR50">
<span class="label">50.</span><cite>Rong Z, Xu J, Yang J, Wang W, Tang R, Zhang Z, et al. CircRREB1 mediates metabolic reprogramming and stemness maintenance to facilitate pancreatic ductal adenocarcinoma progression. Cancer Res<em>.</em> 2024;84:4246â€“63.</cite> [<a href="https://doi.org/10.1158/0008-5472.CAN-23-3596" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/39288082/" class="usa-link">PubMed</a>]</li>
<li id="CR51">
<span class="label">51.</span><cite>Chen B, Deng Y, Hong Y, Fan L, Zhai X, Hu H, et al. Metabolic recoding of NSUN2-mediated m(5)C modification promotes the progression of colorectal cancer via the NSUN2/YBX1/m(5)C-ENO1 positive feedback loop. Adv Sci. 2024;11:e2309840.</cite> [<a href="https://doi.org/10.1002/advs.202309840" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC11267267/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38769664/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Chen%20B,%20Deng%20Y,%20Hong%20Y,%20Fan%20L,%20Zhai%20X,%20Hu%20H,%20et%20al.%20Metabolic%20recoding%20of%20NSUN2-mediated%20m(5)C%20modification%20promotes%20the%20progression%20of%20colorectal%20cancer%20via%20the%20NSUN2/YBX1/m(5)C-ENO1%20positive%20feedback%20loop.%20Adv%20Sci.%202024;11:e2309840." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR52">
<span class="label">52.</span><cite>Jiang, Qiu D, Peng T, Li J, Tala S, Ren W, et al. YB-1 is a positive regulator of KLF5 transcription factor in basal-like breast cancer. Cell Death Differ. 2022;29:1283â€“95.
</cite> [<a href="https://doi.org/10.1038/s41418-021-00920-x" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9177637/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35022570/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Jiang,%20Qiu%20D,%20Peng%20T,%20Li%20J,%20Tala%20S,%20Ren%20W,%20et%20al.%20YB-1%20is%20a%20positive%20regulator%20of%20KLF5%20transcription%20factor%20in%20basal-like%20breast%20cancer.%20Cell%20Death%20Differ.%202022;29:1283%E2%80%9395." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR53">
<span class="label">53.</span><cite>Hao Q, Zhang M, Wu Y, Guo Y, Zheng Y, Wu L, et al. Hsa_circRNA_001676 accelerates the proliferation, migration and stemness in colorectal cancer through regulating miR-556-3p/G3BP2 axis. Sci Rep. 2023;13:18353.
</cite> [<a href="https://doi.org/10.1038/s41598-023-45164-6" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10603078/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37884630/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Hao%20Q,%20Zhang%20M,%20Wu%20Y,%20Guo%20Y,%20Zheng%20Y,%20Wu%20L,%20et%20al.%20Hsa_circRNA_001676%20accelerates%20the%20proliferation,%20migration%20and%20stemness%20in%20colorectal%20cancer%20through%20regulating%20miR-556-3p/G3BP2%20axis.%20Sci%20Rep.%202023;13:18353." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR54">
<span class="label">54.</span><cite>Chen Y, Zhou S, Wan K, Yu L, Zhao C, Deng H, et al. RIOK1 mediates p53 degradation and radioresistance in colorectal cancer through phosphorylation of G3BP2. Oncogene. 2022;41:3433â€“44.
</cite> [<a href="https://doi.org/10.1038/s41388-022-02352-4" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35589951/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Chen%20Y,%20Zhou%20S,%20Wan%20K,%20Yu%20L,%20Zhao%20C,%20Deng%20H,%20et%20al.%20RIOK1%20mediates%20p53%20degradation%20and%20radioresistance%20in%20colorectal%20cancer%20through%20phosphorylation%20of%20G3BP2.%20Oncogene.%202022;41:3433%E2%80%9344." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
</ul></section></section><section id="_ad93_" lang="en" class="associated-data"><h2 class="pmc_sec_title">Associated Data</h2>
<p class="font-secondary"><em>This section collects any data citations, data availability statements, or supplementary materials included in this article.</em></p>
<section id="_adsm93_" lang="en" class="supplementary-materials"><h3 class="pmc_sec_title">Supplementary Materials</h3>
<section class="sm xbox font-sm" id="db_ds_supplementary-material1_reqid_"><div class="media p"><div class="caption">
<a href="/articles/instance/12335500/bin/41419_2025_7929_MOESM1_ESM.docx" data-ga-action="click_feat_suppl" class="usa-link">Supplementary materials</a><sup> (1.7MB, docx) </sup>
</div></div></section><section class="sm xbox font-sm" id="db_ds_supplementary-material2_reqid_"><div class="media p"><div class="caption">
<a href="/articles/instance/12335500/bin/41419_2025_7929_MOESM2_ESM.pdf" data-ga-action="click_feat_suppl" class="usa-link">uncropped western blots</a><sup> (7.8MB, pdf) </sup>
</div></div></section><section class="sm xbox font-sm" id="db_ds_supplementary-material3_reqid_"><div class="media p"><div class="caption">
<a href="/articles/instance/12335500/bin/41419_2025_7929_MOESM3_ESM.xlsx" data-ga-action="click_feat_suppl" class="usa-link">RT-qPCR original data</a><sup> (15.9KB, xlsx) </sup>
</div></div></section></section><section id="_adda93_" lang="en" class="data-availability-statement"><h3 class="pmc_sec_title">Data Availability Statement</h3>
<p>All data are available upon reasonable request.</p></section></section></section><footer class="p courtesy-note font-secondary font-sm text-center"><hr class="headless">
<p>Articles from Cell Death &amp; Disease are provided here courtesy of <strong>Nature Publishing Group</strong></p></footer></section></article>

                      

                    </main>
                </div>
            </div>
        </div>

        



<!-- Secondary navigation placeholder -->
<div class="pmc-sidenav desktop:grid-col-4 display-flex">
    <section class="pmc-sidenav__container" aria-label="Article resources and navigation">
        <button type="button" class="usa-button pmc-sidenav__container__close usa-button--unstyled">
            <img src="/static/img/usa-icons/close.svg" role="img" alt="Close" />
        </button>
    <div class="display-none desktop:display-block">
       <section class="margin-top-4 desktop:margin-top-0">
              <h2 class="margin-top-0">ACTIONS</h2>
           <ul class="usa-list usa-list--unstyled usa-list--actions">
               
               <li>
                     <a
                             href="https://doi.org/10.1038/s41419-025-07929-x"
                             class="usa-button usa-button--outline width-24 font-xs display-inline-flex flex-align-center flex-justify-start padding-left-1"
                             target="_blank"
                             rel="noreferrer noopener"
                             data-ga-category="actions"
                             data-ga-action="click"
                             data-ga-label="publisher_link_desktop"
                     >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#launch"></use>
                         </svg>
                         <span class="display-inline-flex flex-justify-center flex-1 padding-right-2">View on publisher site</span>
                     </a>
               </li>
               
               
               <li>
                    <a
                            href="pdf/41419_2025_Article_7929.pdf"
                            class="usa-button usa-button--outline width-24 display-inline-flex flex-align-center flex-justify-start padding-left-1"
                            data-ga-category="actions"
                            data-ga-action="click"
                            data-ga-label="pdf_download_desktop"
                    >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#file_download"></use>
                        </svg>
                        <span class="display-inline-flex flex-justify-center flex-1">PDF (5.1Â MB)</span>
                    </a>
               </li>
               
                
               <li>
                   <button role="button" class="usa-button width-24 citation-dialog-trigger display-inline-flex flex-align-center flex-justify-start padding-left-1"
                        aria-label="Open dialog with citation text in different styles"
                        data-ga-category="actions"
                        data-ga-action="open"
                        data-ga-label="cite_desktop"
                        data-all-citations-url="/resources/citations/12335500/"
                        data-citation-style="nlm"
                        data-download-format-link="/resources/citations/12335500/export/"
                    >
                        <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#format_quote"></use>
                        </svg>
                       <span class="display-inline-flex flex-justify-center flex-1 button-label">Cite</span>
                    </button>
               </li>
                
               <li>

                        <button class="usa-button width-24 collections-dialog-trigger collections-button display-inline-flex flex-align-center flex-justify-start padding-left-1 collections-button-empty"
                              aria-label="Save article in MyNCBI collections."
                              data-ga-category="actions"
                              data-ga-action="click"
                              data-ga-label="collections_button_desktop"
                              data-collections-open-dialog-enabled="false"
                              data-collections-open-dialog-url="https://account.ncbi.nlm.nih.gov/?back_url=https%3A%2F%2Fpmc.ncbi.nlm.nih.gov%2Farticles%2FPMC12335500%2F%3Freport%3Dclassic%23open-collections-dialog"
                              data-in-collections="false">
                            <svg class="usa-icon width-3 height-3 usa-icon--bookmark-full" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-full.svg#icon"></use>
                            </svg>
                            <svg class="usa-icon width-3 height-3 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-empty.svg#icon"></use>
                            </svg>
                            <span class="display-inline-flex flex-justify-center flex-1">Collections</span>
                       </button>
               </li>
               <li class="pmc-permalink">
                    <button
                            type="button"
                            class="usa-button width-24 display-inline-flex flex-align-center flex-justify padding-left-1 shadow-none"
                            aria-label="Show article permalink"
                            aria-expanded="false"
                            aria-haspopup="true"
                            data-ga-category="actions"
                            data-ga-action="open"
                            data-ga-label="permalink_desktop"
                    >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#share"></use>
                        </svg>
                        <span class="display-inline-flex flex-justify-center flex-1 button-label">Permalink</span>
                    </button>
                   

<div class="pmc-permalink__dropdown" hidden>
    <div class="pmc-permalink__dropdown__container">
          <h2 class="usa-modal__heading margin-top-0 margin-bottom-2 text-uppercase font-sans-xs">PERMALINK</h2>
          <div class="pmc-permalink__dropdown__content">
              <input type="text" class="usa-input" value="https://pmc.ncbi.nlm.nih.gov/articles/PMC12335500/" aria-label="Article permalink">
              <button class="usa-button display-inline-flex pmc-permalink__dropdown__copy__btn margin-right-0" title="Copy article permalink" data-ga-category="save_share" data-ga-action="link" data-ga-label="copy_link">
                  <svg class="usa-icon" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#content_copy"></use>
                  </svg>
                  <span class="margin-left-1">Copy</span>
              </button>
          </div>
    </div>
</div>
               </li>
           </ul>
       </section>
     </div>

        <section class="pmc-resources margin-top-6 desktop:margin-top-4" data-page-path="/articles/PMC12335500/">
            <h2 class="margin-top-0">RESOURCES</h2>
            
                <div class="usa-accordion usa-accordion--multiselectable" data-allow-multiple>
                    <h3 class="usa-accordion__heading">
                        <button
                        type="button"
                        class="usa-accordion__button"
                        aria-expanded="false"
                        aria-controls="resources-similar-articles"
                        data-ga-category="resources_accordion"
                        data-ga-action="open_similar_articles"
                        data-ga-label="/articles/PMC12335500/"
                        data-action-open="open_similar_articles"
                        data-action-close="close_similar_articles"
                        >
                            Similar articles
                        </button>
                    </h3>
                    <div
                            id="resources-similar-articles"
                            class="usa-accordion__content usa-prose"
                            
                                data-source-url="/resources/similar-article-links/40783393/"
                            
                    >
                        
                    </div>
                    <h3 class="usa-accordion__heading">
                        <button
                        type="button"
                        class="usa-accordion__button"
                        aria-expanded="false"
                        aria-controls="resources-cited-by-other-articles"
                        data-ga-category="resources_accordion"
                        data-ga-action="open_cited_by"
                        data-ga-label="/articles/PMC12335500/"
                        data-action-open="open_cited_by"
                        data-action-close="close_cited_by"
                        >
                             Cited by other articles
                        </button>
                    </h3>
                    <div
                            id="resources-cited-by-other-articles"
                            class="usa-accordion__content usa-prose"
                            
                                data-source-url="/resources/cited-by-links/40783393/"
                            
                    >
                          
                    </div>
                    
                        <h3 class="usa-accordion__heading">
                            <button
                            type="button"
                            class="usa-accordion__button"
                            aria-expanded="false"
                            aria-controls="resources-links-to-ncbi-databases"
                            data-ga-category="resources_accordion"
                            data-ga-action="open_NCBI_links"
                            data-ga-label="/articles/PMC12335500/"
                            data-action-open="open_NCBI_links"
                            data-action-close="close_NCBI_link"
                            >
                                 Links to NCBI Databases
                            </button>
                        </h3>
                        <div
                                id="resources-links-to-ncbi-databases"
                                class="usa-accordion__content usa-prose"
                                data-source-url="/resources/db-links/12335500/"
                        >
                        </div>
                    
                    
                </div>
            
        </section>


        <section
        class="usa-in-page-nav usa-in-page-nav--wide margin-top-6 desktop:margin-top-4"
        data-title-text="On this page"
        data-title-heading-level="h2"
        data-scroll-offset="0"
        data-root-margin="-10% 0px -80% 0px"
        data-main-content-selector="main"
        data-threshold="1"
        hidden
        ></section>
    </section>
</div>


        

<div class="overlay" role="dialog" aria-label="Citation Dialog" hidden>
    <div class="dialog citation-dialog" aria-hidden="true">
        <div class="display-inline-flex flex-align-center flex-justify width-full margin-bottom-2">
            <h2 class="usa-modal__heading margin-0">Cite</h2>
             <button type="button" class="usa-button usa-button--unstyled close-overlay text-black width-auto"  tabindex="1">
                <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#close"></use>
                </svg>
             </button>
        </div>

        

<div class="citation-text-block">
  <div class="citation-text margin-bottom-2"></div>
  <ul class="usa-list usa-list--unstyled display-inline-flex flex-justify width-full flex-align-center">
      <li>
        <button
          class="usa-button usa-button--unstyled text-no-underline display-flex flex-align-center copy-button dialog-focus"
          data-ga-category="save_share"
          data-ga-action="cite"
          data-ga-label="copy"
          tabindex="2">
            <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                <use xlink:href="/static/img/sprite.svg#content_copy"></use>
            </svg>
            <span>Copy</span>
        </button>
      </li>
      <li>
          <a
              href="#"
              role="button"
              class="usa-button usa-button--unstyled text-no-underline display-flex flex-align-center export-button"
              data-ga-category="save_share"
              data-ga-action="cite"
              data-ga-label="download"
              title="Download a file for external citation management software"
              tabindex="3">
                <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#file_download"></use>
                </svg>
                <span class="display-none mobile-lg:display-inline">Download .nbib</span>
                <span class="display-inline mobile-lg:display-none">.nbib</span>
            </a>
      </li>
      <li>
          

<div class="display-inline-flex flex-align-center">
  <label class="usa-label margin-top-0">Format:</label>
  <select aria-label="Format" class="usa-select citation-style-selector padding-1 margin-top-0 border-0 padding-right-4" tabindex="4" >
    
      <option data-style-url-name="ama"
              value="AMA"
              >
        AMA
      </option>
    
      <option data-style-url-name="apa"
              value="APA"
              >
        APA
      </option>
    
      <option data-style-url-name="mla"
              value="MLA"
              >
        MLA
      </option>
    
      <option data-style-url-name="nlm"
              value="NLM"
              selected="selected">
        NLM
      </option>
    
  </select>
</div>
      </li>
  </ul>
</div>
    </div>
</div>

        <div class="overlay" role="dialog" hidden>
  <div id="collections-action-dialog" class="dialog collections-dialog" aria-hidden="true">
   <div class="display-inline-flex flex-align-center flex-justify width-full margin-bottom-2">
        <h2 class="usa-modal__heading margin-0">Add to Collections</h2>
    </div>
    <div class="collections-action-panel action-panel">
      


<form id="collections-action-dialog-form"
      class="usa-form maxw-full collections-action-panel-form action-panel-content action-form action-panel-smaller-selectors"
      data-existing-collections-url="/list-existing-collections/"
      data-add-to-existing-collection-url="/add-to-existing-collection/"
      data-create-and-add-to-new-collection-url="/create-and-add-to-new-collection/"
      data-myncbi-max-collection-name-length="100"
      data-collections-root-url="https://www.ncbi.nlm.nih.gov/myncbi/collections/">

    <input type="hidden" name="csrfmiddlewaretoken" value="hDa0KuEM1NbXPxxRKxjxal9d3RhM16OHogDYbxGOLimoytmxQsfLuN0KMPwWlJOS">

    <fieldset class="usa-fieldset margin-bottom-2">
        <div class="usa-radio">
            <input type="radio"
            id="collections-action-dialog-new"
            class="usa-radio__input usa-radio__input--tile collections-new  margin-top-0"
            name="collections"
            value="new"
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="collections_radio_new" />
            <label class="usa-radio__label" for="collections-action-dialog-new">Create a new collection</label>
        </div>
        <div class="usa-radio">
            <input type="radio"
            id="collections-action-dialog-existing"
            class="usa-radio__input usa-radio__input--tile collections-existing"
            name="collections"
            value="existing"
            checked="true"
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="collections_radio_existing" />
            <label class="usa-radio__label" for="collections-action-dialog-existing">Add to an existing collection</label>
        </div>
    </fieldset>

    <fieldset class="usa-fieldset margin-bottom-2">
        <div class="action-panel-control-wrap new-collections-controls">
           <label for="collections-action-dialog-add-to-new" class="usa-label margin-top-0">
                Name your collection
               <abbr title="required" class="usa-hint usa-hint--required text-no-underline">*</abbr>
          </label>
          <input
            type="text"
            name="add-to-new-collection"
            id="collections-action-dialog-add-to-new"
            class="usa-input collections-action-add-to-new"
            pattern="[^&quot;&amp;=&lt;&gt;/]*" title="The following characters are not allowed in the Name field: &quot;&amp;=&lt;&gt;/"
            maxlength=""
            data-ga-category="collections_button"
            data-ga-action="create_collection"
            data-ga-label="non_favorties_collection"
            required
          />
        </div>
        <div class="action-panel-control-wrap existing-collections-controls">
             <label for="collections-action-dialog-add-to-existing" class="usa-label margin-top-0">
                Choose a collection
              </label>
              <select id="collections-action-dialog-add-to-existing"
                      class="usa-select collections-action-add-to-existing"
                      data-ga-category="collections_button"
                      data-ga-action="select_collection"
                      data-ga-label="($('.collections-action-add-to-existing').val() === 'Favorites') ? 'Favorites' : 'non_favorites_collection'">
              </select>
              <div class="collections-retry-load-on-error usa-input-error-message selection-validation-message">
                Unable to load your collection due to an error<br>
                <a href="#">Please try again</a>
              </div>
        </div>
    </fieldset>

    <div class="display-inline-flex">
        <button class="usa-button margin-top-0 action-panel-submit"
            type="submit"
            data-loading-label="Adding..."
            data-pinger-ignore
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="add">
          Add
        </button>
        <button class="usa-button usa-button--outline margin-top-0 action-panel-cancel"
                aria-label="Close 'Add to Collections' panel"
                ref="linksrc=close_collections_panel"
                data-ga-category="collections_button"
                data-ga-action="click"
                data-ga-label="cancel">
          Cancel
        </button>
    </div>
</form>
    </div>
  </div>
</div>

        

      </div>
    </div>
  </div>



        
    
    

<footer class="ncbi-footer ncbi-dark-background " >
    
        <div class="ncbi-footer__icon-section">
            <div class="ncbi-footer__social-header">
                Follow NCBI
            </div>

            <div class="grid-container ncbi-footer__ncbi-social-icons-container">
                
                    <a href="https://twitter.com/ncbi"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="40"
                             height="40"
                             viewBox="0 0 40 40"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="m6.067 8 10.81 13.9L6 33.2h4.2l8.4-9.1 7.068 9.1H34L22.8 18.5 31.9 8h-3.5l-7.7 8.4L14.401 8H6.067Zm3.6 1.734h3.266l16.8 21.732H26.57L9.668 9.734Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on X (formerly known as Twitter)</span>
                    </a>
                

                
                    <a href="https://www.facebook.com/ncbi.nlm"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="16"
                             height="29"
                             focusable="false"
                             aria-hidden="true"
                             viewBox="0 0 16 29"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg">
                            <path d="M3.8809 21.4002C3.8809 19.0932 3.8809 16.7876 3.8809 14.478C3.8809 14.2117 3.80103 14.1452 3.54278 14.1492C2.53372 14.1638 1.52334 14.1492 0.514288 14.1598C0.302626 14.1598 0.248047 14.0972 0.248047 13.8936C0.256034 12.4585 0.256034 11.0239 0.248047 9.58978C0.248047 9.37013 0.302626 9.30224 0.528931 9.3049C1.53798 9.31688 2.54837 9.3049 3.55742 9.31555C3.80103 9.31555 3.8809 9.26097 3.87957 9.00272C3.87158 8.00565 3.85428 7.00592 3.90753 6.00884C3.97142 4.83339 4.31487 3.73115 5.04437 2.78467C5.93095 1.63318 7.15699 1.09005 8.56141 0.967577C10.5582 0.79319 12.555 0.982221 14.5518 0.927641C14.7102 0.927641 14.7462 0.99287 14.7449 1.13664C14.7449 2.581 14.7449 4.02668 14.7449 5.47104C14.7449 5.67604 14.6517 5.68669 14.4946 5.68669C13.4523 5.68669 12.4113 5.68669 11.3703 5.68669C10.3506 5.68669 9.92057 6.10868 9.90593 7.13904C9.89661 7.7647 9.91525 8.39303 9.89794 9.01869C9.88995 9.26364 9.96583 9.31822 10.2015 9.31688C11.7204 9.30623 13.2393 9.31688 14.7595 9.3049C15.0257 9.3049 15.0723 9.3728 15.0444 9.62439C14.89 10.9849 14.7515 12.3467 14.6144 13.7085C14.5691 14.1571 14.5785 14.1585 14.1458 14.1585C12.8386 14.1585 11.5313 14.1665 10.2254 14.1518C9.95119 14.1518 9.89794 14.2317 9.89794 14.4899C9.90593 19.0799 9.89794 23.6752 9.91125 28.2612C9.91125 28.5674 9.8407 28.646 9.53186 28.6433C7.77866 28.6273 6.02414 28.6366 4.27094 28.634C3.82499 28.634 3.87158 28.6992 3.87158 28.22C3.87602 25.9472 3.87913 23.6739 3.8809 21.4002Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on Facebook</span>
                    </a>
                

                
                    <a href="https://www.linkedin.com/company/ncbinlm"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="25"
                             height="23"
                             viewBox="0 0 26 24"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M14.6983 9.98423C15.6302 9.24808 16.5926 8.74754 17.6762 8.51991C19.673 8.09126 21.554 8.30824 23.1262 9.7526C24.2351 10.7723 24.7529 12.1115 25.0165 13.5612C25.1486 14.3363 25.2105 15.1218 25.2015 15.9081C25.2015 18.3043 25.2015 20.6898 25.2082 23.0806C25.2082 23.3468 25.1549 23.444 24.8621 23.4414C23.1297 23.4272 21.3992 23.4272 19.6704 23.4414C19.4041 23.4414 19.3429 23.3588 19.3442 23.1019C19.3535 20.5194 19.3442 17.9368 19.3442 15.3543C19.3442 14.0005 18.3258 12.9448 17.0266 12.9488C15.7273 12.9528 14.6983 14.0071 14.6983 15.361C14.6983 17.9328 14.6917 20.5047 14.6983 23.0753C14.6983 23.3708 14.6198 23.444 14.3296 23.4427C12.6185 23.4294 10.9079 23.4294 9.19779 23.4427C8.93155 23.4427 8.86099 23.3735 8.86232 23.1086C8.8783 19.7619 8.88628 16.4144 8.88628 13.066C8.88628 11.5688 8.87874 10.0708 8.86365 8.57182C8.86365 8.3575 8.90758 8.27896 9.14054 8.28029C10.9048 8.29094 12.6687 8.29094 14.4321 8.28029C14.6464 8.28029 14.6983 8.34818 14.6983 8.54653C14.6903 9.00047 14.6983 9.45441 14.6983 9.98423Z">
                            </path>
                            <path d="M6.55316 15.8443C6.55316 18.2564 6.55316 20.6699 6.55316 23.082C6.55316 23.3629 6.48127 23.4388 6.19906 23.4374C4.47737 23.4241 2.75568 23.4241 1.03399 23.4374C0.767751 23.4374 0.69986 23.3629 0.701191 23.1006C0.709178 18.2648 0.709178 13.4281 0.701191 8.59053C0.701191 8.34026 0.765089 8.27237 1.01669 8.2737C2.74991 8.28435 4.48048 8.28435 6.20838 8.2737C6.47462 8.2737 6.5465 8.33627 6.54517 8.6065C6.54783 11.0186 6.55316 13.4308 6.55316 15.8443Z">
                            </path>
                            <path d="M3.65878 0.243898C5.36804 0.243898 6.58743 1.45529 6.58743 3.1406C6.58743 4.75801 5.32145 5.95742 3.60819 5.96807C3.22177 5.97614 2.83768 5.90639 2.47877 5.76299C2.11985 5.61959 1.79344 5.40546 1.51897 5.13334C1.24449 4.86123 1.02755 4.53668 0.881058 4.17902C0.734563 3.82136 0.661505 3.43788 0.666231 3.05141C0.67555 1.42601 1.9362 0.242566 3.65878 0.243898Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on LinkedIn</span>
                    </a>
                

                
                    <a href="https://github.com/ncbi"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="28"
                             height="27"
                             viewBox="0 0 28 28"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M16.7228 20.6334C17.5057 20.5527 18.2786 20.3944 19.0301 20.1608C21.3108 19.4193 22.5822 17.8259 22.963 15.4909C23.1228 14.5112 23.1814 13.5287 22.9883 12.5437C22.8106 11.6423 22.4013 10.8028 21.8007 10.1076C21.7526 10.0605 21.7197 10 21.7064 9.934C21.6931 9.86799 21.7 9.79952 21.7262 9.73748C22.0856 8.6206 21.9711 7.51969 21.601 6.42677C21.582 6.3497 21.5345 6.2827 21.468 6.23923C21.4016 6.19577 21.3211 6.17906 21.2429 6.19248C20.7329 6.21649 20.2313 6.33051 19.7611 6.52928C19.1103 6.7908 18.4899 7.12198 17.9104 7.51703C17.84 7.56996 17.7581 7.60551 17.6713 7.62078C17.5846 7.63605 17.4954 7.6306 17.4112 7.60489C15.2596 7.05882 13.0054 7.06203 10.8554 7.61421C10.7806 7.63586 10.7018 7.63967 10.6253 7.62534C10.5487 7.611 10.4766 7.57892 10.4148 7.53167C9.64788 7.03247 8.85171 6.58918 7.96368 6.33359C7.65781 6.24338 7.34123 6.19458 7.02239 6.18849C6.94879 6.17986 6.87462 6.19893 6.81432 6.242C6.75402 6.28507 6.71191 6.34904 6.69621 6.42145C6.32342 7.51437 6.2209 8.61527 6.56307 9.73348C6.59635 9.84264 6.64694 9.93316 6.54177 10.0516C5.47666 11.2604 5.09988 12.6834 5.19574 14.2676C5.2663 15.4244 5.46201 16.5466 6.01454 17.5769C6.84399 19.1171 8.21664 19.9119 9.85158 20.3352C10.3938 20.4706 10.9444 20.5698 11.4998 20.632C11.5384 20.7492 11.4506 20.7798 11.408 20.8291C11.1734 21.1179 10.9894 21.4441 10.8634 21.7942C10.7622 22.0458 10.8315 22.4039 10.6065 22.5516C10.263 22.7766 9.83827 22.8485 9.42421 22.8871C8.17936 23.0056 7.26471 22.4877 6.6283 21.4348C6.25552 20.8184 5.76956 20.3325 5.08523 20.0663C4.76981 19.9325 4.42139 19.8967 4.08537 19.9638C3.7898 20.029 3.73788 20.1901 3.93891 20.4111C4.03639 20.5234 4.14989 20.6207 4.27575 20.6999C4.9796 21.1318 5.51717 21.7884 5.80152 22.5636C6.37002 23.9973 7.48039 24.5697 8.93825 24.6323C9.43741 24.6575 9.93768 24.615 10.4254 24.5058C10.5892 24.4672 10.6531 24.4872 10.6517 24.6762C10.6451 25.4936 10.6637 26.3123 10.6517 27.131C10.6517 27.6635 10.1684 27.9297 9.58663 27.7393C8.17396 27.2671 6.84977 26.5631 5.66838 25.656C2.59555 23.2891 0.720966 20.1861 0.217704 16.3376C-0.357453 11.9127 0.911353 8.00824 3.98551 4.73881C6.11909 2.42656 8.99932 0.939975 12.1203 0.540191C16.5351 -0.0601815 20.4347 1.14323 23.7232 4.16373C26.2449 6.47869 27.724 9.37672 28.1048 12.7726C28.5828 17.0325 27.3686 20.7945 24.4768 23.9827C22.9762 25.6323 21.0956 26.8908 18.9982 27.6488C18.8783 27.6927 18.7585 27.738 18.636 27.7726C18.0356 27.9404 17.6189 27.6395 17.6189 27.0098C17.6189 25.7452 17.6308 24.4806 17.6295 23.2159C17.6329 22.9506 17.6128 22.6856 17.5696 22.4238C17.4325 21.6664 17.3419 21.484 16.7228 20.6334Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on GitHub</span>
                    </a>
                

                
                    <a href="https://ncbiinsights.ncbi.nlm.nih.gov/"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="26"
                             height="26"
                             viewBox="0 0 27 27"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M23.7778 26.4574C23.1354 26.3913 22.0856 26.8024 21.636 26.3087C21.212 25.8444 21.4359 24.8111 21.324 24.0347C19.9933 14.8323 14.8727 8.80132 6.09057 5.85008C4.37689 5.28406 2.58381 4.99533 0.779072 4.99481C0.202773 4.99481 -0.0229751 4.83146 0.00455514 4.21479C0.0660406 3.08627 0.0660406 1.95525 0.00455514 0.826734C-0.0413285 0.0815827 0.259669 -0.0193618 0.896534 0.00266238C6.96236 0.222904 12.3693 2.24179 16.9889 6.16209C22.9794 11.2478 26.1271 17.7688 26.4372 25.648C26.4629 26.294 26.3179 26.5271 25.6609 26.4684C25.0827 26.417 24.4991 26.4574 23.7778 26.4574Z">
                            </path>
                            <path d="M14.8265 26.441C14.0924 26.441 13.2371 26.6795 12.6626 26.3786C12.0092 26.0372 12.3781 25.0644 12.246 24.378C11.1154 18.5324 6.6849 14.5497 0.74755 14.1001C0.217135 14.0615 -0.0104482 13.9422 0.0134113 13.3659C0.0519536 12.1454 0.0482829 10.9213 0.0134113 9.69524C-0.00127145 9.14464 0.196946 9.03268 0.703502 9.04736C9.21217 9.27128 16.5994 16.2511 17.2804 24.7231C17.418 26.4446 17.418 26.4446 15.6579 26.4446H14.832L14.8265 26.441Z">
                            </path>
                            <path d="M3.58928 26.4555C2.64447 26.4618 1.73584 26.0925 1.06329 25.4289C0.39073 24.7653 0.00933763 23.8617 0.0030097 22.9169C-0.00331824 21.9721 0.365937 21.0635 1.02954 20.3909C1.69315 19.7184 2.59675 19.337 3.54156 19.3306C4.48637 19.3243 5.39499 19.6936 6.06755 20.3572C6.7401 21.0208 7.1215 21.9244 7.12782 22.8692C7.13415 23.814 6.7649 24.7226 6.10129 25.3952C5.43768 26.0677 4.53409 26.4491 3.58928 26.4555Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI RSS feed</span>
                    </a>
                
            </div>
        </div>
    

    <div data-testid="gridContainer"
         class="grid-container ncbi-footer__container">
        <div class="grid-row ncbi-footer__main-content-container"
             data-testid="grid">
            
                <div class="ncbi-footer__column">
                    
                        <p class="ncbi-footer__circled-icons-heading">
                            Connect with NLM
                        </p>
                    

                    <div class="ncbi-footer__circled-icons-list">
                        
                            <a href=https://twitter.com/nlm_nih class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="32"
                                     height="32"
                                     viewBox="0 0 40 40"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="m6.067 8 10.81 13.9L6 33.2h4.2l8.4-9.1 7.068 9.1H34L22.8 18.5 31.9 8h-3.5l-7.7 8.4L14.401 8H6.067Zm3.6 1.734h3.266l16.8 21.732H26.57L9.668 9.734Z">
                                    </path>
                                </svg>
                                <span class="usa-sr-only">NLM on X (formerly known as Twitter)</span>
                            </a>
                        

                        
                            <a href=https://www.facebook.com/nationallibraryofmedicine class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="13"
                                     height="24"
                                     viewBox="0 0 13 24"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="M4.11371 23.1369C4.11371 23.082 4.11371 23.0294 4.11371 22.9745V12.9411H0.817305C0.6709 12.9411 0.670898 12.9411 0.670898 12.8016C0.670898 11.564 0.670898 10.3287 0.670898 9.09341C0.670898 8.97903 0.705213 8.95158 0.815017 8.95158C1.8673 8.95158 2.91959 8.95158 3.97417 8.95158H4.12057V8.83263C4.12057 7.8055 4.12057 6.7738 4.12057 5.74897C4.1264 4.92595 4.31387 4.11437 4.66959 3.37217C5.12916 2.38246 5.94651 1.60353 6.95717 1.1921C7.64827 0.905008 8.3913 0.764035 9.13953 0.778051C10.0019 0.791777 10.8644 0.830666 11.7268 0.860404C11.8869 0.860404 12.047 0.894717 12.2072 0.90158C12.2964 0.90158 12.3261 0.940469 12.3261 1.02968C12.3261 1.5421 12.3261 2.05452 12.3261 2.56465C12.3261 3.16857 12.3261 3.7725 12.3261 4.37642C12.3261 4.48165 12.2964 4.51367 12.1912 4.51138C11.5369 4.51138 10.8804 4.51138 10.2261 4.51138C9.92772 4.51814 9.63058 4.5526 9.33855 4.61433C9.08125 4.6617 8.84537 4.78881 8.66431 4.97766C8.48326 5.16652 8.3662 5.40755 8.32972 5.66661C8.28476 5.89271 8.26027 6.1224 8.25652 6.35289C8.25652 7.19014 8.25652 8.02969 8.25652 8.86923C8.25652 8.89439 8.25652 8.91955 8.25652 8.95615H12.0219C12.1797 8.95615 12.182 8.95616 12.1614 9.10714C12.0768 9.76596 11.9876 10.4248 11.9029 11.0813C11.8312 11.6319 11.7626 12.1824 11.697 12.733C11.6719 12.9434 11.6787 12.9434 11.4683 12.9434H8.26338V22.899C8.26338 22.979 8.26338 23.0591 8.26338 23.1392L4.11371 23.1369Z">
                                    </path>
                                </svg>
                                <span class="usa-sr-only">NLM on Facebook</span>
                            </a>
                        

                        
                            <a href=https://www.youtube.com/user/NLMNIH class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="21"
                                     height="15"
                                     viewBox="0 0 21 15"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="M19.2561 1.47914C18.9016 1.15888 18.5699 0.957569 17.2271 0.834039C15.5503 0.678484 13.2787 0.655608 11.563 0.65332H9.43556C7.71987 0.65332 5.4483 0.678484 3.77151 0.834039C2.43098 0.957569 2.097 1.15888 1.74242 1.47914C0.813665 2.32097 0.619221 4.62685 0.598633 6.89384C0.598633 7.31781 0.598633 7.74101 0.598633 8.16345C0.626084 10.4121 0.827391 12.686 1.74242 13.521C2.097 13.8412 2.4287 14.0425 3.77151 14.1661C5.4483 14.3216 7.71987 14.3445 9.43556 14.3468H11.563C13.2787 14.3468 15.5503 14.3216 17.2271 14.1661C18.5676 14.0425 18.9016 13.8412 19.2561 13.521C20.1712 12.6929 20.3725 10.451 20.3999 8.22064C20.3999 7.74025 20.3999 7.25986 20.3999 6.77946C20.3725 4.54907 20.1689 2.30724 19.2561 1.47914ZM8.55942 10.5311V4.65201L13.5601 7.50005L8.55942 10.5311Z"
                                          fill="white" />
                                </svg>
                                <span class="usa-sr-only">NLM on YouTube</span>
                            </a>
                        
                    </div>
                </div>
            

            
                <address class="ncbi-footer__address ncbi-footer__column">
                    
        <p>
            <a class="usa-link usa-link--external"
            href="https://www.google.com/maps/place/8600+Rockville+Pike,+Bethesda,+MD+20894/%4038.9959508,
            -77.101021,17z/data%3D!3m1!4b1!4m5!3m4!1s0x89b7c95e25765ddb%3A0x19156f88b27635b8!8m2!3d38.9959508!
            4d-77.0988323"
            rel="noopener noreferrer" target="_blank">National Library of Medicine
            <br/> 8600 Rockville Pike<br/> Bethesda, MD 20894</a>
        </p>
    
                </address>
            

            
                <ul class="usa-list usa-list--unstyled ncbi-footer__vertical-list ncbi-footer__column">
                    
                        <li class="ncbi-footer__vertical-list-item">
                            








<a href="https://www.nlm.nih.gov/web_policies.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
    

    Web Policies

    
</a>

                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            








<a href="https://www.nih.gov/institutes-nih/nih-office-director/office-communications-public-liaison/freedom-information-act-office" class="usa-link  usa-link--alt ncbi-footer__link"  >
    

    FOIA

    
</a>

                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            








<a href="https://www.hhs.gov/vulnerability-disclosure-policy/index.html" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
    

    HHS Vulnerability Disclosure

    
</a>

                        </li>
                    
                </ul>
            

            
                <ul class="usa-list usa-list--unstyled ncbi-footer__vertical-list ncbi-footer__column">
                    
                        <li class="ncbi-footer__vertical-list-item">
                            








<a href="https://support.nlm.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
    

    Help

    
</a>

                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            








<a href="https://www.nlm.nih.gov/accessibility.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
    

    Accessibility

    
</a>

                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            








<a href="https://www.nlm.nih.gov/careers/careers.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
    

    Careers

    
</a>

                        </li>
                    
                </ul>
            
        </div>

        
            <div class="grid-row grid-col-12" data-testid="grid">
                <ul class="ncbi-footer__bottom-links-list">
                    
                        <li class="ncbi-footer__bottom-list-item">
                            








<a href="https://www.nlm.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
    

    NLM

    
</a>

                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            








<a href="https://www.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
    

    NIH

    
</a>

                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            








<a href="https://www.hhs.gov/" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
    

    HHS

    
</a>

                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            








<a href="https://www.usa.gov/" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
    

    USA.gov

    
</a>

                        </li>
                    
                </ul>
            </div>
        
    </div>
</footer>

    


        
        
    
  <script  type="text/javascript" src="https://cdn.ncbi.nlm.nih.gov/core/pinger/pinger.js"> </script>


    
        

<button class="back-to-top" data-ga-category="pagination" data-ga-action="back_to_top">
    <label>Back to Top</label>
    <svg class="usa-icon order-0" aria-hidden="true" focusable="false" role="img">
        <use xlink:href="/static/img/sprite.svg#arrow_upward"></use>
    </svg>
</button>
    


        
    
    
    
        
    <script type="application/javascript">
    window.ncbi = window.ncbi || {};
    window.ncbi.pmc = window.ncbi.pmc || {};
    window.ncbi.pmc.options = {
        logLevel: 'INFO',
        
        staticEndpoint: '/static/',
        
        citeCookieName: 'pmc-cf',
    };
</script>
    <script type="module" crossorigin="" src="/static/assets/base-370d5dd6.js"></script>
    
    <script type="text/javascript" src="https://cdn.ncbi.nlm.nih.gov/core/jquery/jquery-3.6.0.min.js">&#xA0;</script>
    <script type="text/javascript">
        jQuery.getScript("https://cdn.ncbi.nlm.nih.gov/core/alerts/alerts.js", function () {
            galert(['div.nav_and_browser', 'div.header', '#universal_header', '.usa-banner', 'body > *:nth-child(1)'])
        });
    </script>


    <script type="text/javascript">var exports = {};</script>
     <script src="/static/CACHE/js/output.13b077bc3ffd.js"></script>

    <script type="module" crossorigin="" src="/static/assets/article-917ba005.js"></script>
    
    

    </body>
</html>
